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Abstract 
DNA is constantly under the assault of many kinds of damage, both of exogenous and 
endogenous origin. The very replication of DNA molecules is a major source of this 
second kind of injury, for its impairment can generate a panel of toxic intermediates, 
where both sister chromatids are linked through DNA linkages. These structures are 
constantly monitored and cleared oﬀ in cells by two independent pathways, 
denominated dissolution and resolution. While the latter is catalyzed by structure-
speciﬁc nucleases including MUS81, GEN1 and SLX1/SLX4, dissolution is known to be 
operated through the coordinated action of the helicase BLM and the topoisomerase 
TOPIIIα. A wealth of data from lower eukaryotes suggest that a complex known as 
SMC5/6, related to condensin and cohesin, might also be involved in dissolution – yet its 
contribution along this pathway in mammals is largely uncharacterized. We here used 
mouse models to explore a potential role of the SMC5/6 complex in dissolution in 
mammals. For this purpose, we employed a recently published Smc6 mutant allele, as 
well as a new allele that carries a mutation on Nsmce2, a SUMO ligase which is an 
essential functional component of the SMC5/6 complex.  
Our data show that the Nsmce2SUMOdead allele generated is indeed severely compromised 
in its SUMO ligase activity. Surprisingly, whereas some signs of genomic instability can be 
detected in Nsmce2 mutants in vitro, our results suggests that NSMCE2-dependent 
SUMOylation is largely dispensable for ﬁtness in vivo. In addition, we ﬁnd a severe 
synthetic lethality between the resolution resolvase MUS81, and the Smc6-impairing 
mutation we employed. These results help to substantiate a role for SMC5/6 in 
dissolution in mammals, and to dimension the role that SUMOylation might play within 
the SMC5/6 complex. Besides dissolution, this work explored two aspects of the 
resolution pathway - namely, a potential role for resolution nucleases on the 
phenomenon of “chromosome pulverization”, and the implementation of cell-systems 
where the activity of these nucleases can be unleashed at will.  
Collectively, my PhD tried to explore the concepts of resolution and dissolution of joint 
DNA molecules, something that has mostly been investigated using yeast as a model 
system. 
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Resumen 
El ADN está constantemente sometido al asalto de muchos tipos de agentes dañinos, 
tanto de origen exógeno como endógeno. La replicación del genoma es una fuente 
importante de este segundo tipo de lesión, por su capacidad de generar una serie de 
productos intermedios tóxicos, formados por cromátidas unidas a través del ADN. Estas 
estructuras son constantemente eliminadas en las células a través de dos mecanismos 
independientes conocidos como disolución y resolución. Mientras este último es 
catalizado por nucleasas estructura-especíﬁcas, denominadas MUS81, GEN1 y SLX1/
SLX4, la disolución opera a través de la acción coordinada de la helicasa BLM y de la 
topoisomerasa TOPIIIα. Datos recientes en eucariotas inferiores sugieren que el 
complejo denominado SMC5/6, relacionado estructuralmente con condensina y 
cohesina, juega un papel fundamental en la disolución. Sin embargo, su contribución en 
metazoos no se ha caracterizado en detalle todavía. Para este trabajo, con el ﬁn de 
explorar un posible papel del complejo SMC5/6 en mediar la disolución en mamíferos, 
desarrollamos y empleamos modelos de ratón mutante por SMC6, así como un nuevo 
alelo inactivante la actividad SUMO ligasa de NSMCE2, un componente esencial del 
complejo SMC5/6. Nuestros datos demuestran la efectiva abrogación functional del alelo 
NSMCE2SUMOdead . Sorprendentemente, mientras encontramos signos de inestabilidad 
genómica en mutantes de Nsmce2 in vitro, los resultados expuestos sugieren que la 
SUMOylación mediada por NSMCE2 es prescindible para la supervivencia in vivo. 
Además, pudimos remarcar una severa letalidad sintética entre la mutación de la 
endonucleasa MUS81 y la mutación de SMC6 que empleamos. Estos resultados 
corroboran el papel de SMC5/6 en la disolución de los mamíferos, redimensionando la 
importancia de la SUMOylación operada por NSMCE2 en este contexto. Durante este 
trabajo caracterizamos también la resolución y su posible papel en el fenómeno de la 
"pulverización de los cromosomas". En conclusión, diseñamos un sistema artiﬁcial para 
implementar la actividad de estas nucleasas en células.  
Colectivamente, durante mi doctorado intentamos caracterizar genéticamente, y a nivel 
molecular, la disolución y la resolución de las moléculas de ADN conjuntas, fenómenos 
que, a fecha de hoy, se han caracterizado principalmente en levadura. 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Introduction
Introduction 
DNA molecules: a robust yet fallible substrate to store information 
Observing the history of life backwards in time, we can certainly conclude that the DNA 
strategy to transmit information through generations has proven to be a rather 
successful one. 
DNA molecules present numerous advantages as an information vehicle: the 
“information density” of DNA - a measure of the amount of information theoretically 
recordable on a certain substrate - surpasses that of many digital media currently used 
today.  Its chemo-physical properties, moreover, make it a remarkably stable and robust 
support (Bancroft, Bowler et al. 2001; Church, Gao et al. 2012). 
Despite its intrinsic stability and versatility though, DNA molecules are prone to damage 
and therefore, alteration of the encoded information.!
A plethora of environmental agents, such as ionizing radiations and reactive oxygen 
species (ROS) as an example, can corrupt the chemical backbone of the molecule, 
aﬀecting the information stored. In addition, the same outcome may result from the 
constant wear and tear that DNA undergoes during its replication (Groth, Rocha et al. 
2007). Despite being the driving force of evolution, mutations and DNA damage often 
result in negative eﬀects on the survival of organisms. In order to preserve ﬁtness, the 
issue has obviously to be dealt with, and it is hence of no surprise that a selective 
pressure for repair strategies has taken place since the earliest stages of life. DNA repair 
pathways have indeed been described for almost all the diﬀerent threats that can 
assault DNA molecules, and cells can implement a variety of cooperative and alternative 
approaches in order to restore the status quo ante after the establishment of damage 
(Bartek and Lukas 2007; Branzei and Foiani 2005; Sancar, Lindsey-Boltz et al. 2004). 
Such is the case for the response elicited by lesions arising at DNA replication - an 
important source of endogenous damage. 
Replication and cellular DNA metabolism are a major source of replication 
intermediates. 
The complex array of operations necessary for the duplication of DNA molecules, with its 
intrinsic (and inevitable) imperfection, as well as the action of DNA damaging agents 
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during the process, may halt replication, and consequently  lead to the accumulation of 
DNA replication intermediates (ﬁgure 1) (Lönn and Lönn 1985; Lönn, Lönn et al. 1990; 
Segurado, Gomez et al. 2002; Sogo, Lopes et al. 2002; Mankouri, Huttner et al. 2013). 
Figure 1: replication arrest leads to the accumulation of DNA replication intermediates. Arrested 
replication forks leave behind DNA replication intermediates, also known as joint DNA species, that may 
assume diﬀerent conﬁgurations depending on the source of damage that originated them (Aguilera and 
Gómez-González, 2008). 
Some of these structures can lead to joint DNA molecules which can assume diﬀerent 
conﬁgurations and topologies. These represent a major issue, for they can degenerate, 
at cell division, in DNA bridges, hampering the correct segregation of chromosomes to 
daughter cells (Chan, North et al. 2007; Shimizu, Shingaki et al. 2005). In eukaryotic cells, 
mis-segregation often results in chromosomal aberrations at anaphase: micronuclei and 
double minutes chromosomes may arise, resulting in gene copy number variations and, 
potentially, aberrant expression patterns that can lead to malignancy (Chen and Chen 
2008; Ogiwara, Kohno et al. 2008; Smida, Baumhoer et al. 2010). Additionally, the 
breakage of DNA bridges can generate exposed fragments of DNA, prone to 
recombination, with the risk of producing loss of heterozygosity (LOH) and wreaking 
havoc on the genome, as in the case of several chromosomal instability syndromes 
!18
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(ﬁgure 2) (Gupta, Sahota et al. 1997; Luo, Santoro et al. 2000; Ogiwara, Kohno et al. 
2008).  
Figure 2: unprocessed DNA joint molecules may give rise to chromosomal aberrations at 
anaphase. When pulled apart at anaphase, intertwined chromatids may undergo breakage. The 
resulting fragments, which are not inherited by both daughter cells, may give rise to micronuclei 
or DM chromosomes. Additionally, exposed ssDNA originating from the rupture may promote 
unbalanced recombination, leading to LOH and gross chromosomal rearrangements.  
!19
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Dissolution and resolution deal with accumulated replication intermediates in 
cells. 
Due to their peculiar topology, replication intermediates are processed in cells by a well-
orchestrated enzymatic machinery involving at its operative core topoisomerases, 
helicases and structure-speciﬁc nucleases.  
While the ﬁrst are enzymes catalyzing the under/over-winding of DNA ﬁlaments, the 
second operate by separating two annealed nucleic acid strands using the energy 
derived from ATP. Members of the third class can instead generate cuts on the DNA 
molecules by cleaving the phosphodiester bonds between its nucleotide subunits. !
Upon the accumulation of replication intermediates, cells can operate the dissolution of 
these structures (ﬁgure 3). The ﬁnal goal of the process, which involves helicases and 
topoisomerases, is the disentanglement of two sister chromatids of replicated DNA 
intertwined together, allowing their correct separation at anaphase. The gene Blm 
encodes for the major helicase implicated in dissolution (Cheok, Bachrati et al. 2005), a 
task that it accomplishes through the functional partnership with topoisomerase IIIα 
(Yang, Bachrati et al. 2010) and the accessory partners RMI1/RMI2 (Cejka, Plank et al. 
2010). Together with WRN, BLM belongs to the family of the ReqQ helicases (Karow, 
Chakraverty et al. 1997), and both enzymes are the respective etiological causes of the 
Werner and Bloom syndromes, two autosomal recessive disorders characterized by a 
striking genomic instability (Mohaghegh, Karow et al. 2001; Shen and Loeb 2000; 
Yamagata, Kato et al. 1998).  !
Alternatively, yet to a certain extent cooperatively, replication intermediates can undergo 
a independent process, known as resolution (ﬁgure 3), which involves the structure 
speciﬁc nucleases encoded by Gen1, Slx1, and Mus81 in metazoans (Boddy, Gaillard et al. 
2001; Doe, Ahn et al. 2002; Schwartz and Heyer, 2011). The cut produced by these 
nucleases, similarly to the case of dissolution, results in the separation of the two sister 
chromatids (Rass, 2013). (ﬁgure 3) The DSB produced for the separation needs though 
to undergo repair by homologous recombination (HR). This last process may lead, in half 
of the cases, to sister chromatid exchanges, bearing the intrinsic potential to generate 
chromosomal instability and LOH if not correctly performed.  A fourth gene, Slx4, plays 
an important role by encoding SLX4, a coordinating docking protein orchestrating the 
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activity of SLX1 and MUS81, at least in human cells (Cybulski and Howlett 2011; Muñoz, 
Hain et al. 2009; Wyatt, Sarbajna et al. 2013). 
Figure 3: dissolution and resolution are the housekeeping pathways dealing with accumulated 
replication intermediates. Resolution and dissolution are catalyzed by diﬀerent enzymatic complex which 
concur to the clearance of toxic DNA replication intermediates 
Dissolution and resolution: a paradigmatic example of redundancy of function. 
The monitoring of replication intermediates well summarizes the idea of redundancy, a 
common feature of many biological processes. Metaphorically, we can imagine cells 
proceeding along a path, from replication to division, as outlined in ﬁgure 4. 
Figure 4: a traﬃcking metaphor to illustrate the processing of DNA replication intermediates - #1. 
Whenever joint DNA molecules accumulate after replication, they can alternatively undergo resolution or 
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dissolution, allowing cells to proceed safely towards cell division and avoiding thus potential genomic 
distress.  
At the end of replication, they will have accumulated DNA replication intermediates and 
in order to continue towards a risk-free cell division, two distinct ways are possible. If 
either of the two is not available, a redundant backup track is present to provide an 
escape route, allowing DNA joint molecules to be traﬃcked without major issues. 
Should both ways be impaired though, as in ﬁgure 5, the processing of replication 
intermediates is impeded, and their subsequent accumulation obstacles the physical 
disentanglement of chromosomes before the onset of anaphase. As a result, during the 
repartition of DNA to daughter cells, the vast array of chromosomal aberrations 
previously delineated can arise. 
Figure 5: a traﬃcking metaphor to illustrate the processing of DNA replication intermediates - #2. 
When both resolution and dissolution are impaired, DNA joint molecules accumulate after replication, 
bringing about the eﬀects commonly observed in several genomic instability syndromes (Imamura, Fujita et 
al. 2002). 
The situation recapitulates what observed in the case of the Bloom syndrome and 
certain subtypes of Fanconi anemia. The hallmark of Blm mutations is a dramatic 
increase in the frequency of sister chromatid exchanges, resulting from the inoperability 
of dissolution and the exclusive channelling through resolution of DNA replication 
intermediates. In agreement with what expected, the impairment of resolution produces 
genomic instability, too: interestingly, Slx4 has been recently described as a novel FANC 
gene (Kim, Lach et al. 2011; Stoepker, Hain et al. 2011). Finally, a wealth of literature 
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spanning from yeast to Drosophila, highlights the synthetic lethality between sgs1/Blm 
mutants and the resolution nucleases, underlining their pivotal functional interplay 
(Andersen, Kuo et al. 2011; Fabre, Chan et al. 2002). 
A detailed overview of the dissolution machinery 
The protein BLM was discovered and characterized in the '90s as the etiological agent of 
Bloom’s syndrome (OMIM: 210900) (Ellis, Groden, et al. 1995; Karow, Chakraverty et al. 
1997). The hallmark feature of Bloom patients is premature ageing, resulting from of a 
variety of morphological and functional abnormalities aﬀecting several tissues and 
organs. At the cellular level, mutations in Blm typically induce a dramatic chromosomal 
instability, extensive chromosome breakage and, as mentioned, a manifold increase in 
the rate of sister chromatid exchanges. 
BLM – TOPIIIα are the eﬀectors of dissolution  
The enzymatic mechanism of dissolution, catalyzed by the complex BLM-Sgs1/TOPIIIα 
(ﬁgure 6) (Yang, Bachrati et al. 2010), has been well characterized in yeast. At ﬁrst, the 
helicase activity of Sgs1/BLM promotes the branch migration of the crossed junctions 
between strands (as in ﬁgure 6), merging them into a single element (Hickson and 
Mankouri 2011). TopIIIα (Top3a), moving along the DNA strand with Sgs1, takes care of 
reducing the torsional stress generated by the helicase activity of Sgs1 (Gangloﬀ, 
McDonald et al. 1994). Finally, by a transient nick on the single DNA strand exposed by 
the helicase, Top3a allows the disentanglement of the paired ﬁlaments of the replication 
intermediate (Pommier, Pourquier et al. 1998).  
Resolution is promoted by several structure speciﬁc nucleases 
Similarly to the case of dissolution, the simpler biology of yeast helped to provide a 
mechanistic description of the structure-speciﬁc nucleases implicated in resolution 
(ﬁgure 6). As previously mentioned, several genes are involved in the process in 
metazoans, the best characterized among them being Mus81, for historical reasons. The 
nuclease Mus81 is a crossover junction nuclease, ﬁrstly described in yeast as a gene 
protecting against MMS and UV radiation-induced damage (Interthal and Heyer 2000). 
More in detail, the enzyme, which associates to Mms4/EME1 to exert its function (Boddy, 
Gaillard et al. 2001; Doe, Ahn et al. 2002; Fabre, Chan et al. 2002), has been deﬁned as a 
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3' ﬂap nuclease, with a speciﬁcity towards cruciform DNA structures arising at collapsed 
replication forks (Gaillard, Noguchi et al. 2003). In comparison to Mus81, our knowledge 
on the function of Yen1/GEN1 and the complex Slx1/Slx4 is much more recent and 
superﬁcial. YEN1, the yeast orthologous of human GEN1, was originally associated to the 
processing of Okazaki fragments in replicating cells, suggesting a role as a 5' ﬂap 
nuclease (Johnson, Kovvali et al. 1998). Only more recently the catalytic activity of human 
GEN1 towards DNA cruciform structures and Holliday Junctions has been demonstrated 
in vitro (Ip, Rass et al. 2008), the same being true for the complex SLX1/SLX4. These 
proteins take their name from their synthetic lethality (SL) in the absence of Sgs1/BLM in 
yeast (Mullen, Kaliraman et al. 2001), and they operate as a holocomplex. SLX1 
participates as the nucleolytic partner, exerting its activity towards 5' DNA ﬂaps and 
cruciform structures (Fricke and Brill 2003). SLX4 acts instead as a regulatory subunit, 
coordinating, as docking platform, the activity of SLX1 with MUS81 in vivo (ﬁgure 6) 
(Castor, Nair et al. 2013; Fekairi, Scaglione et al. 2009). 
!
Figure 6: an overview of the diﬀerent molecular machineries implicated in the metabolism of Joint 
DNA species. Helicases, such as BLM, can catalyze, together with class 1A topoisomerases the dissolution of 
joint DNA molecules. Resolution involves instead multi-enzymatic complexes, including MUS81 and its 
functional partner, EME1 (Boddy, Gaillard et al. 2001), GEN1 and the SLX1/SLX4 complex (Svendsen and 
Harper 2010).!
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Dissolution and resolution are poorly characterized in vivo 
Despite a rather thorough biochemical characterization of their mode of action in vitro, 
these enzymatic complexes are still poorly characterized in vivo, especially in higher 
eukaryotes. Importantly, there’s a major gap to ﬁll concerning their interplay and the 
regulation of their activity, though recently tentative models have been proposed 
(Matos, Blanco et al. 2011). Due to its strong relevance to cancer, the great interest in 
dissecting the mechanisms preventing DNA replication intermediates comes as no 
surprise. 
While major attention has been historically dedicated to the direct role of nucleases and 
helicases, the attention recently drifted towards more unexplored avenues, such as the 
overall orchestration of dissolution and resolution and its framing inside the cell cycle. 
The predictable interplay of other proteins in the process represents a vastly unexplored 
scenario.  
Experiments performed in lower eukaryotes pinpointed at a panel of evolutionarily 
conserved genes, whose mutation phenocopies mutants for the core molecular 
machinery of dissolution and resolution.  
The SMC5/6 complex – a fundamental genome caretaker 
Among the plethora of enzymes genetically interacting with the dissolution and 
resolution machinery (ﬁgure 7), an interesting group of proteins, denominated SMC (an 
acronym standing for Structural Maintenance of Chromosome) stands out for its pivotal role 
as chromosome caretakers. 
The members of this family, which comprehends cohesin, condensin and the SMC5/6 
heterodimer, are implicated in segregation, transcription, as well as in replication and 
the repair of damaged chromosomes (Hirano 2006; Losada and Hirano 2005; Nasmyth 
and Haering 2005; Wendt and Peters 2009). 
!
!
!
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Figure 7: the SMC5/6 complex genetically interacts with the DNA replication intermediates 
machinery. When analyzing the genetic interactions between the resolution and dissolution machineries, 
the family of genes implicated in the SMC5/SMC6 complex shows up as a genetic linking hub connecting the 
two pathways. (Elaborated from GeneMania.org / © University of Toronto).  
A wealth of yeast literature has highlighted, during time, the importance of the SMC5/6 
heterodimer in several aspects of chromosomal biology. It is best characterized for its 
involvement in the correct repair by homologous recombination (Pebernard, McDonald 
et al. 2004; Torres-Rosell, Sunjevaric et al. 2007). Importantly, SMC5 and SMC6 are 
essential genes in yeast, while the HR related ones are not (Krogh and Symington 2004). 
There are additional indications on its functional implication in gene expression 
regulation (Cuperus and Shore 2002; Dhillon and Kamakaka 2000; Yu, Kuzmiak et al. 
2010; Zhao and Blobel 2005), as well as on its fundamental involvement in replication 
and the dissolution of chromosomes during cell division (Bermudez-Lopez, Ceschia et al. 
2010; De Piccoli, Potts 2009; Torres-Rosell et al. 2009). 
The architecture of the SMC5/SMC6 complex 
The SMC5/6 heterodimer shares its overall topology and structural features with cohesin 
and condensin, the other members of the SMC family. All these contain a central α−helical 
region, at whose ends two globular domains are present (ﬁgure 8).  
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Both the N-terminal and the C-terminal globular domain comprehend a walker A and 
walker B motif, respectively. A third domain, denominated hinge domain, is found in the 
middle of the helical region. Its name is due to its localization at the point where the 
SMC proteins fold back on themselves.  
The tertiary structure of SMC proteins is such to bring the Walker motifs together, 
forming an ATPase connected to the hinge via the coiled coil of α−helical stretches.  
Similarly to the case of cohesin and condensin (Arumugam, Gruber et al. 2003; Kimura and 
Hirano 1997), yeast Smc5/6 possesses an ATPase activity which is speciﬁcally stimulated 
by double-strand DNA (Fousteri and Lehmann 2000).  
Noteworthy, point mutations in the ATP-binding domain of SMC6 render cells sensitive 
to DNA-damaging agents and promote rather than suppress recombination (Ju, Wing et 
al. 2013; Verkade, Bugg et al. 1999). 
Figure 8: SMC proteins share common secondary, tertiary and quaternary structures. Cohesin, 
condensin and both SMC5 and SMC6 are formed by α-helical coils linking together two globular domains at 
the N and C termini. All SMC proteins fold back on themselves through a hinge domain in the middle of the 
α-helical stretch. The prototypical quaternary structure of the SMC heterodimers, as well as an EM image of 
its conformation, is depicted (adapted from Hirano 2002). 
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SMC5/6: a diverse and multitasking complex 
The heterodimer SMC5/6 acts as the backbone of a multimeric complex comprising six 
additional subunits, denominated non-structural maintenance of chromosome elements 
(Nse), as in ﬁgure 9 (Fousteri and Lehmann 2000; Fujioka, Kimata et al. 2002; Hazbun, 
Malmström et al. 2003; McDonald, Pavlova et al. 2003; Morikawa, Morishita et al. 2004; 
Pebernard, McDonald et al. 2004; Zhao and Blobel 2005).  
In budding yeast, Nse proteins are named Nse1, Mms21/Nse2, Nse3, Nse4/Qri2, Nse5, 
and Kre29/Nse6. In ﬁssion yeast instead, Smc6 is identiﬁed as Rad18, Smc5 as Spr18, 
and Nse4 as Rad62 (Fousteri and Lehmann 2000; Morikawa, Morishita et al. 2004; 
Verkade, Bugg et al. 1999). The complex has a diﬀerent organization in metazoans. Out 
of the eight proteins described in lower eukaryotes, only six human orthologous (SMC5, 
SMC6, NSE1, NSMCE2/MMS21, NSE3/MAGE1 and NSE4) have been shown to form a 
complex in vivo (Taylor, Moghraby et al. 2001; Harvey, Sheedy et al. 2004; Potts and Yu 
2005). 
Figure 9: Several additional subunits associate to the SMC5/6 backbone. The SMC5/6 
complex comprehends a number of associated NSE proteins (6 have been described in lower 
eukaryotes, with only 4 shared in metazoan). Apart from possessing an ATPase activity (Fousteri 
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and Lehmann 2000), the associated proteins NSE1 and NSE2/NSMCE2/Mms21 bring to the 
complex their ubiquitin and a SUMO ligase activity respectively (Pebernard, Perry et al. 2008; 
Potts and Yu 2005). 
SMC5/6 is an essential complex playing a role in DNA repair 
The biology of the SMC5/6 complex has been mostly characterized in yeast, where both 
the core elements, as well as some of the associated Nse proteins are shown to be 
essential for cell viability (Fousteri and Lehmann 2000; Fujioka, Kimata et al. 2002; 
Lehmann, Walicka et al. 1995; McDonald, Pavlova et al. 2003).  
Numerous studies demonstrate that cells carrying hypomorphic alleles of these genes 
show increased sensitivity to a broad spectrum of DNA damaging agents, like ionizing 
radiation, UV, and methyl methanesulfonate (MMS) (Fousteri and Lehmann 2000; Fujioka, 
Kimata et al. 2002; Hu, Liao et al. 2005; Lehmann, Walicka et al. 1995; McDonald, Pavlova 
et al. 2003; Onoda, Takeda et al. 2004; Pebernard, McDonald et al. 2004; Torres-Rosell, 
Machin et al. 2005).  
The SMC5/6 complex, moreover, has been associated, in ﬁssion yeast, to the correct 
segregation of chromosomes at mitosis (Torres-Rosell, Machin et al. 2005; Verkade, Bugg 
et al. 1999). Similarly, budding yeast cells carrying hypomorphic alleles of smc6 undergo 
mitotic catastrophe, due to unresolved inter-chromosomal linkages (Farmer, San-
Segundo et al. 2011).  
A general summary of the phenotypes associated to Smc5/6 mutations is presented in 
table 1. 
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Table 1: mutations aﬀecting the SMC5/6 and associated phenotypes across species. Mutations in 
SMC5, SMC6 or associated NSE proteins generally aﬀect DNA repair and the resistance of organisms to DNA 
damaging agents, as well as the correct segregation of chromosomes at both meiosis and mitosis (Farmer, 
San-Segundo et al. 2011; Jessberger 2002; Torres-Rosell. 2005; Verkade, Bugg et al. 1999). 
!
The SMC5/6 complex possesses SUMO ligase activity, provided by NSE2/NSMCE2 
Interestingly, among the essential proteins involved in the SMC5/6 complex, Nse1 
contains a RING ﬁnger domain, analogous to that of E3 ubiquitin ligases, while Nse2/
NSMCE2/Mms21 bears a SP-RING domain, related to the SUMO ligases of the PIAS family 
(McDonald, Pavlova et al. 2003).  Whilst the enzymatic activity of yeast Nse1 could only 
be proven in vitro upon the co-presence of puriﬁed Nse3 (Pebernard, Perry et al. 2008), 
diﬀerent studies, ranging from yeast to human, have conﬁrmed Mms21/NSMCE2 as an 
active SUMO E3 ligase (Andrews, Palecek et al. 2005; Potts and Yu 2005).  
SUMO is a ubiquitin-like protein that can be covalently conjugated to targets (Gill 2004; 
Johnson 2004). Similarly to ubiquitin, the SUMOylation of substrates is catalyzed by a 
chain reaction involving an E1 SUMO-activating enzyme (AOS1-UBA2), a subsequent E2 
conjugating enzyme (UBC9) and ﬁnally, an E3 SUMO ligase (such as Mms21/NSMCE2). 
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The importance of SUMOylation in the context of genomic instability is supported by a 
wealth of literature, highlighting how numerous proteins participating in DNA repair 
undergo SUMO modiﬁcation and SUMO-mediated regulation (Eladad, Ye et al. 2005; 
Hoege, Pfander et al. 2002;  Jackson and Durocher 2013; Pfander, Moldovan et al. 2005; 
Sacher, Pfander et al. 2006; Saitoh, Pizzi et al. 2002).  
NSE2/NSMCE2 is a SUMO ligase with fundamental implications in DNA repair 
The alternative name for NSMCE2 in yeast – MMS21 – recalls its history.  
It has been, for a long time, a rather anonymous gene, ﬁrst described in 1977 as a 
mutant conferring MMS-sensitivity and a signiﬁcant increase in spontaneous mitotic 
recombination in yeast (Prakash and Prakash 1977). Upon the recent discovery of its 
SUMO ligase activity (Andrews, Palecek et al. 2005) NSMCE2/MMS21 has gained 
momentum, partially due to the paucity of E3 SUMO ligases encoded in eukaryotic 
genomes. Additional progress on its characterization has been made, principally in 
yeast, where the protein was shown to be physically associated to the coiled-coil region 
of Smc5 (Zhao and Blobel 2005). In terms of its biochemistry, Mms21/Nse2 was shown to 
autoSUMOylate and promote the SUMOylation of two substrate proteins, Smc5 and 
Ku70 (Zhao and Blobel 2005). The S. pombe Nse2 stimulates instead the SUMOylation of 
Smc6 and Nse3, but not Smc5 or Nse1 (Andrews, Palecek et al. 2005). If only a handful of 
substrates for Mms21/NSMCE2 have been characterized during time in both yeast and 
metazoans, it is now clear that the protein plays a dichotomic role in the SMC5/6 
complex. Despite being essential, budding and ﬁssion yeast cells bearing SUMO ligase-
impairing mutations in NSMCE2 are viable, though they remain hypersensitive to DNA 
damaging agents (Andrews, Palecek et al. 2005; Zhao and Blobel 2005). These results 
suggest that the SUMO ligase activity of Mms21 is not required for its essential function, 
but is important for a fully proﬁcient DNA damage response.  
NSMCE2 is implicated in the prevention of recombination processing of DNA 
replication intermediates 
Apart from its general implication in DNA repair, yeast MMS21 has been shown to play a 
speciﬁc and pivotal role in the prevention of recombination and the accumulation of 
joint DNA molecules arising at replication, or during HR-mediated repair. Yeast mms21 
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mutants, where the C-terminal SP-RING domain is disrupted, accumulate joint DNA 
molecules at damaged replication forks (Branzei, Sollier et al. 2006).  
Importantly, these observations are recapitulated when employing an alternative mutant 
strain of yeast carrying two missense mutations (C200A; H202A) that can disrupt the SUMO 
ligase activity of the protein (Andrews, Palecek et al. 2005).  
In summary, the NSMCE2-mediated SUMOylation regulates the process that counteracts 
the accumulation of DNA cruciform structures during replication.  
NSMCE2 mutations induce the accumulation of joint DNA molecules (phenocopying 
Blm/Sgs1 mutations) 
An important feature of yeast sgs1/Blm mutant cells, similarly to metazoans, is the 
accumulation DNA cruciform structures upon the induction of DNA damage (Fabre, 
Chan et al. 2002; Kaliraman, Mullen et al. 2001). Diﬀerently from higher eukaryotic cells 
though, these can be directly visualized through 2D electrophoresis gels in yeast (Liberi, 
Maﬃoletti et al. 2005). By taking advantage of this technique, diﬀerent groups could 
emphasize how yeast mutants for the SUMO ligase activity of Mms21 show the same 
pattern of joint DNA molecules accumulation as sgs1 mutants (Bermudez-Lopez, Ceschia 
et al. 2010; Branzei, Sollier et al. 2006). Considering that Sgs1 is SUMOylated in budding 
yeast (Lu, Tsai et al. 2010), an intriguing corollary of this phenotypical overlap could hence 
be the functional interplay between the dissolution machinery and the SMC5/6 complex, 
mediated, possibly, by the SUMO ligase activity of NSMCE2/Mms21.  
The SMC5/6 complex playing a role in dissolution? An open possibility to explore. 
Preliminary experiments failed to show the rather straightforward hypothesis of Mms21 
SUMOylating Sgs1 (Branzei, Sollier et al. 2006), leaving a rather undeﬁned scenario 
around the plausible regulatory role of the SMC5/6 in dissolution.  
Several lines of evidence are indeed pointing at this possibility. For instance, mutants for 
Smc5/Smc6 are synthetic lethal with sgs1 and mus81 in yeast, as well as with mms4/Eme1 
(the functional partner of Mus81) and slx4-slx1 (Cost and Cozzarelli 2006; Morikawa, 
Morishita et al. 2004; Pebernard, McDonald et al. 2004; Torres-Rosell, Machin et al. 
2005). Moreover, as previously discussed, SMC5/6 mutations aﬀect the correct 
segregation of chromosomes at mitosis and meiosis, similarly to sgs1/Blm mutants 
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(Bermudez-Lopez, Ceschia et al. 2010; Branzei, Sollier et al. 2006). Additionally, 
mutations in mms21, a preeminent functional element of the SMC5/6 heterodimer, induce 
an increase in recombination rates (Prakash and Prakash 1977), again phenocopying 
sgs1 mutants.  Finally, additional evidence from S. pombe links the functional integrity of 
the SMC5/6 complex to the prevention of DNA replication intermediates (Lindroos, 
Strom et al. 2006). 
We therefore cannot but conclude that further investigation on the genetic equivalence 
between dissolution mutants - SMC5/6 would indeed be a sensible and enthralling 
endeavour which could help shedding a light on its physiological role. All this being 
particularly true in higher eukaryotes, where a thorough characterization on the speciﬁc 
proteins implicated is still vastly lacking. 
For this reason, we envisaged the possibility of developing a novel set of murine models, 
aimed at demonstrating the hypothesis of a role for the SMC5/6 multimeric complex in 
regulating the accumulation of joint DNA molecules. 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Objectives  
Objectives 
• To analyze the role of the SMC5/6 complex in mammals by the use of a SUMOylation 
deﬁcient allele of NSMCE2. 
• To explore the genetic interaction between the SMC5/6 complex and structure-speciﬁc 
nucleases involved on the resolution of intermolecular DNA links. 
• To investigate a potential role of mitotic kinases and structure-speciﬁc nucleases on 
the phenomenon of “chromosome pulverization” (CP). 
• To generate cellular systems where the activity of structure-speciﬁc nucleases can be 
stimulated at will. 
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Materials and methods  
Materials and methods
Materials and methods 
Mice handling 
Genotypings and maintenance 
All animals used during the development of this thesis were kept in the animal facility of 
the Spanish National Cancer Research Center, according with the Spanish animal 
protection law (R.D. 1201-2005) and the European directive 86/609/CEE established to 
regulate the standards of animal care 
In order to genotype the animals, DNA was extracted from tail samples digested during 
16hrs at 56°C in a lysis buﬀer composed of 100mM NaCl, Tris-HCl pH 8,00 20mM, EDTA 
10mM, SDS 0,5%, proteinase K (Roche) 400 μg/ml. Proteins from the lysates were salted 
out with saturated NaCl and DNA was precipitated with isopropanol 100%, washed with 
ethanol 70% and resuspended in 10 mM Tris-Cl, pH 8,5. Genotyping PCRs were 
performed in a reaction mix composed of 200 μM dNTPs, 1 mM MgCl2, 6mM (NH4)2SO4, 
67 mM Tris-HCl pH 8,8, 1U EcoTaq polymerase (Ecogen/Bioline), 1μM of each primer, ~ 
100 ng of genomic DNA.  
PCR oligonucleotides 
Nsmce2SD-neo: primers amplify a band of 360bp for the wt allele and a band of 560 bp for 
the NSMCE2SUMOdead-neo allele 
 FWD: GGTGGGACTGGAGTATTGGA                  
 REV: TATGTGCGTTGAGTGTGCAA                          
 REV-neo: CAGAAAGCGAAGGAGCAAAG                          
Mus81KO: primers amplify a band of 1087 bp for the KO allele, and a band of 764bp for  
the wt allele. 
 Mus81 wt FWD: ACTCAGCACCACACCGTCCTC 3’                  
 Mus81 wt: REV: CCCACCCAGCCTCAAGCAG                  
 Mus81 KO FWD:  CATTGCGCTCCCTCCAACGGTA                  
 Mus81 KO REV:  GGCCAGCTCATTCCTCCCACTCATG                  
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Smc6S994A-neo: primers amplicons obtained with the following primers 
 FWD: CCCTGGTAAAGCATCCTAACT                            
 REV: CAGGCAAACGCTCAAGATGTAC                            
were subjected to restriction digestion with NaeI (NEB) providing a  digested product 
in the presence of the point mis-sense mutation. 
Nsmce2lox:primers amplicons resulted in a band of 150 bp in the case of the wt 
allele, while the ﬂoxed allele results in a band of 300 bp 
 FWD: ATTAGAAAATAATGATCCTAGGAAACATTAATTCTGCAACTCGTTGTT                            
 REV: TAAATACTCATGCCTTTCTTACCCCGTCTTTCT                            
Slx4lox: primers amplify a product of 550 bp in the case of the ﬂoxed allele and a band of 
480bp in for the wt: 
 FWD: CTTGTGGACTTGGCAGTGG                            
 REV:  GGCTGCTAGGTACCAGGTCC                             
Gen1KO:  the wt PCR product results in a band of 415 bp; the KO allele gives rise to a    
band of 384 bp. 
 FWD: TTTCAGTGTTGCTTTCTGCAA                            
 REVwt: GGCCACTGGCATTAAGGTAA                             
 REVKO: GGGTTATTGAATATGATCGGAAT                            
Survival curves 
At least 15 adult animals (>14 weeks) for every genotype of interest were maintained for 
each survival analysis. The age of death was recorded for each animal and reported on a 
Kaplan-Meyer curve with GraphPad™ (Prism Software).  
Immunohistochemistry 
Tissue samples were embedded in formalin and stained with hematoxylin/eosin, 
following the protocol routinely used at the CNIO pathology unit. 
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Micronucleation/polynucleation scoring - liver sections 
Liver sections embedded in formalin were subjected to hematoxylin/eosin staining and 
analyzed for the presence of micronuclei/polynucleated cells. At least 3 animals were 
scored for each experimental genotype. The number of aberrancies scored were plotted 
as a percentage over the whole sample with GraphPad™ (Prism software). 
Azoxymethane-dextran sulphate induced tumorigenesis 
6/8-week-old experimental mice and wild-type counterparts were injected 
intraperitoneally (i.p.) with 12,5 mg/kg AOM. After ﬁve days 2,5% DSS was given in the 
drinking water over ﬁve days, followed by 16 days of regular water. This cycle was 
repeated twice and mice were sacriﬁced ten days after the last cycle. Colons were 
removed, ﬂushed with PBS, ﬁxed as “Swiss-rolls” in 4% paraformaldehyde at 4°C 
overnight and screened for adenomas. Results were plotted with GraphPad™ (Prism 
software). 
Cellular biology 
Cell culture 
Unless otherwise speciﬁed, all cell lines were cultured in DMEM (4,5g/l glucose; L-Gln) 
(Lonza, CH) complemented with 10% or 20% inactivated fetal bovine serum (FBS) (Lonza) 
and a mixture of penicillin and streptomycin (Gibco/Invitrogen/Life technologies, 
Carlsbad-CA). Cells were grown in 5% CO2 - 37°C, except for murine ﬁbroblasts, grown in 
hypoxic conditions (5% O2).  
Production of MEFs (mouse embryonic ﬁbroblasts) 
Female and male mice of the desired genotypes were mated until vaginal plugs were 
visible. At 13,5 days of gestation (unless otherwise speciﬁed) females were sacriﬁced and 
embryos were extracted and deprived of embryonic liver and spleen. The remainders 
were thus chopped with a sterile blade and incubated for 10 minutes in 1 ml trypsin 
0,25% (Gibco). The resulting mixture was disaggregated by mechanical pipetting and 
trypsin was neutralized with 9ml of DMEM 15% FBS. Cell suspensions were then 
incubated in hypoxic conditions and media changed the following day, to eliminate dead 
cells and undesired, non attached contaminant cell subtypes.   
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Isolation of splenic B lymphocytes 
Splenectomy was performed in mice aged 6/8 weeks. Whole spleens were squeezed in 
PBS and supernatants treated with a hypotonic solution (ACK lysing buﬀer, Lonza) 
during 10 minutes. Supernatant was ﬁltered through a 40 μm strainer and the remaining 
solution centrifuged at 350g during 5 minutes. The precipitate was resuspended in 900 
μl of PBS to which 80 μl of αCD143-conjugated magnetic beads were subsequently 
added (Miltenyi Biotech, Germany). The mixture was incubated for 30 minutes at 4°C 
and after this time, cells were washed, resuspended in 1 ml PBS and transferred to a 
magnetic separation column (MS columns, Miltenyi) attached to a magnetic scaﬀold 
(OctoMACS separator, Miltenyi). The non-retained fraction, containing a pool enriched 
for B-cells, was retained and maintained in culture in RPMI medium (Euroclone/Lonza) 
supplemented with 10% FBS, 1% penicillin/streptomycin, 2mM glutamine (Gibco/
Invitrogen), MEM-Non-Essential amino acid solution (Lonza), 1mM sodium pyruvate 
(Gibco/Invitrogen), 50 mM β-mercaptoethanol (Gibco/Invitrogen), HEPES 10 mM (Lonza) 
and 25 mg/ml LPS (Sigma Aldrich, St. Louis, MO) in order to stimulate cell proliferation.  
Cell proliferation curves 
12500 cells were seeded in triplicate in 24 well plates. Six hours after seeding, they were 
washed in PBS and ﬁxed at timepoints in 2% glutaraldehyde/PBS for 15 minutes. After 
washing with water, ﬁxed cells were stained with a 0,1% crystal violet water solution for 
20 minutes on a rocking platform. After washing three times with water, plates were air 
dried, and crystal violet eluted with 10% acetic acid for 20 minutes on a rocking platform. 
The absorbance at 595 nm for each sample was assayed on a spectrophotometer 
(BioRad) and log values over starting points were plotted.  
Micronucleation/polynucleation quantiﬁcations 
Cells were seeded at a density of 5000/ cell/well in 96 well plates in triplicate and grown 
for 72 hrs in the presence of increasing concentrations of MMS (ranging from 0,025mM 
to 0,5 mM). They were then washed in PBS, ﬁxed in 4% paraformaldehyde/PBS for 10 
minutes at room temperature, rinsed with PBS and stained with a solution of DAPI and 
HCS Deep Red CellMask™ dye (Invitrogen) to stain the cellular body and chromatin 
diﬀerentially. Cells (n>100) were scored for the presence of ≥ 1 micronucleus or nucleus 
and results were plotted as normalized over the minimal count in the control condition.  
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Immunoﬂuorescence/high-throughput immunoﬂuorescence  
Either 10000 cells (96 well plates) or 30000 cells (24 well plates) were seeded and let 
settle for 16 hrs. Attached cells were then treated according to the appropriate 
experimental protocol. They washed 1X with PBS and ﬁxed in 2% paraformaldehyde/PBS 
for 10 minutes at room temperature. Fixed cells were then washed in PBS twice and 
permeabilized with a buﬀer containing 0,1% TritonX-100 in PBS (Sigma-Aldrich) for 5 
minutes at room temperature.  
Where needed, washed cells were ﬁxed and pre-extracted with a mSTF/CSK buﬀer to 
reduce the aspeciﬁc cytoplasmic signal. The STF buﬀer is composed as follows: 150mM 
2-bromo-2-nitro-1,3-propanediol, 108mM diazolidinyl urea, 10mM sodium citrate, 50mM 
EDTA pH 5,7. The CSK is instead composed by 10mM PIPES pH 6,8, 100mM NaCl, 300mM 
sucrose, 3 mM MgCl2, 1mM EGTA, 0,5% Triton X-100.  
Fixed an pre-extracted cells were then permeabilized with a permeabilization buﬀer 
(100mM Tris-HCl pH 7,5, 50mM EDTA, 0,5% Triton X-100) and saturated in a blocking 
solution (2,5% BSA, 0,1% Tween-20, 10% goat serum) for 30 minutes at room 
temperature.  
Cells were then incubated in primary antibody at 4°C for 16hrs, washed in PBS three 
times for 10 minutes at room temperature and decorated with Alexa Fluor® secondary 
antibodies (Invitrogen). After three additional washes in PBS, samples were stained with 
DAPI and mounted. 
High throughput immunoﬂuorescence was performed with the standard protocol 
described above, but using 96 well plates with ﬂattened transparent bottom (Greiner 
Bio-one) instead of regular plates. Images from stained cells were then acquired 
automatically with the Opera™ High Content Screening platform (Perkin Elmer, Waltham, 
MA) in use at the Imaging facility of the CNIO. Quantiﬁcations and data analysis were 
performed with the Acapella® Imaging and analysis software.   
HCS EdU proliferation assays  
When EdU (5-ethynyl-2-deoxyuridine) staining was required to assay cell proliferation in 
high throughput, cells were treated with EdU ranging from 30 minutes to 2 hours, 
depending on the cell type and its replication rate. After EdU incorporation, cells were 
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ﬁxed with 4% paraformaldehyde/PBS at room temperature for 10 minutes and 
processed according to the protocol provided with the Click-it EdU cell proliferation 
assay (Life Technologies).  
BrdU incorporation/metaphase spreads 
In order to discriminate actively proliferating cells, BrdU (5-bromo-2’-deoxyuridine) was 
added to culture medium at a concentration of 10µM. Karyomax Colcemid (Life 
Technologies) was then added to cells for 2 to 5 hours (depending on the cell type) at a 
ﬁnal concentration of 100 ng/ml and metaphase-arrested cells were harvested and 
resuspended in 75mM KCl for 20 mins. Few drops of a freshly prepared ﬁxing solution 
(3:1 methanol/acetic acid) was then added to the resuspension. Cells were then 
centrifuged and  subsequently resuspended in the ﬁxing solution, repeating this latter 
process three times. The cellular pellet obtained was spread on microscopy slides and 
BrdU detection was performed by denaturing the samples with 1,5M HCl for 30 minutes 
at room temperature. Slides were then washed three times in PBS and blocked in a 
solution of 1% BSA/PBS-Tween 0,1% for 30 minutes at room temperature. Finally, slides 
were decorated with a monoclonal αBrdU antibody (Millipore) for 1 hr at RT and a 
secondary AlexaFluor® anti mouse antibody. 
Sister chromatid exchange assays  
When scoring for sister chromatid exchanges, actively proliferating MEFs or B 
lymphocytes were exposed to BrdU at a concentration of 10μM for 5 hours (B cells) or 12 
hours (MEFs) and aphidicholin 0,5 μM for 16 hours.  
Metaphase spreads were produced according to the protocol outlined above and 
subsequently incubated with Hoechst 33258 at a concentration of 10 μg/ml in PBS for 30 
minutes at 37°C. After rinsing in SSC 2X, cells were exposed to UV (λ = 352 nm) for 60 
min) and rinsed in SSC 2X. Finally, they were stained with 3% PBS in Gurr’s buﬀered 
solution for 5 minutes at RT, washed and visualized at the microscope.  
Colony forming assays  
MEFs were seeded in 6-well plates at a density of 12500 cells/well in triplicate. Where 
replication challenging was pursued, they were exposed to a high dose of either MMS 
(ﬁnal concentration of 10 mM) or mytomicin C (MMC) (0,5 μg/ml to 1 μg/ml for 1hr).  
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Cells were then washed in PBS and grown for up to 15 days. The colonies obtained were 
thus ﬁxed in a 1,5% methylene blue/ethanol solution and counted after extensive 
washing.  
Cell transfection - lentiviral and retroviral transductions 
Transfections for transient overexpression and viral productions were performed with 
Lipofectamine 2000 (Invitrogen), according to the manufacturer's standard protocols.  
Viral particles for transduction were produced in 293T cells, transfected with either a 
retroviral packaging vector (pCl-Eco) or a third generation lentiviral platform based on 
the pMDLg/pRRE-pRSV.Rev-pMDG VSV-G packaging vectors (Dull, Zuﬀerey et al. 1998).  
At 48 hours post transfection, the supernatant from the packaging lines was collected, 
ﬁltered and added on top of experimental cells seeded for the purpose, together with 
6µg/ml polybrene. 
Molecular biology/biochemistry 
RNA extraction and gene silencing analysis by RT-PCR 
Roughly 1 million cells were usually harvested by trypsinization and pelleted by 
centrifugation. The pellet obtained was resuspended in Trizol (Invitrogen) and processed 
according to the producer’s standard protocol. Gene silencing was The RNA obtained 
was processed using the SuperScript III Platinum kit (Invitrogen) and the cDNA obtained 
quantiﬁed by real time PCR using the following oligonucleotides: 
GAPDH FWD: CATGATGGCCATGAGGTCCACCAC 
GAPDH REV: GCCACCCAGAAGACTGTGGATGGC 
Murine Slx4 FWD: ATGGAGTGCAAGACTAAGGGG 
Murine Slx4 REV: TGTGGCAAGGGAATTTCTCCT 
Murine Gen1 FWD: CCCGAGTCAGAAATGGAGTCCA 
Murine Gen1 REV: CGCTTCTTCCATTGTAAGGAGGC 
Measurements were normalized to the GAPDH levels of each samples and plotted as 
fold changes over controls. 
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Protein extraction/SDS page electrophoresis/Western blot/Immunoprecipitations 
Protein were extracted from harvested cells lysed in a protein lysis buﬀer (50 mM Tris-
HCl pH 7,4; 150 mM NaCl; 1 mM EDTA; 1 mM EGTA; 270 mM sucrose; 1% Triton-X100) 
supplemented with a mix of protease inhibitors (Sigma-Aldrich) and Benzonase® 
(Merck).Lysates were thus centrifuged at 16000g for 40 minutes at 4°C to pellet cell 
debris.  
Supernantants were thus quantiﬁed/normalized using the Bradford method and directly 
loaded on gels or processed for immunoprecipitations (IP). These where routely 
performed by incubating quantiﬁed/normalized protein lysates with primary antibodies 
against the epitope of interest, together with proteinA/G conjugated Dynabeads® (Life 
Technology) for 16 hrs at 4°C. IP samples were loaded on 4%-12% SDS-PAGE gradient 
gels after heat-mediated denaturalization in NuPage loading buﬀer (Life Technologies). 
Protein gels were then transferred on ECL HybondTM nitrocellulose membranes and 
incubated in blocking buﬀer (10% skimmed milk in TBS/Tween-20 0,05%) for 45 minutes 
at room temperature. Primary antibody incubation for Western blot detection was 
routinely performed at 4°C overnight. Decorated membranes were incubated in HRP-
conjugated secondary antibodies for 1hr at RT and protein levels revealed using the 
SuperSignal West Pico protein detection kit (Pierce).  
SUMOylation assays 
Stable 293T FLP-in cells overexpressing NSMCE2WT or NSMCE2C185S;H187A were transfected 
with constructs encoding for SUMO1-GFP or FLAG-SUMO2 using Lipofectamine 2000 
(Invitrogen). 48 hours post-transfection, cells were harvested and processed as 
following: for SUMO1-GFP overexpressors, lysates were treated accordingly to the 
instruction of the µMACS GFP Isolation Kit (Milenyi Biotec). In the case of FLAG-SUMO2 
overexpression, cells were lysed in the protein lysate buﬀer previously described 
supplemented with 20mM N-ethylmaleimide. Precleared lysates were  thus normalized 
and immunoprecipitated with magnetic anti-FLAG beads (Sigma-Aldrich) for 4 hrs at 4°C. 
After three washes performed with the lysis buﬀer, the immunoprecipitated samples 
were denatured in NuPage buﬀer and loaded on gradient 4-12% SDS-PAGE gels. 
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STREPT-puriﬁcation of SUMOylated proteins 
OneStrept©-tag mediated puriﬁcation of SUMOylated proteins was attained using the 
MagStrep type2 HC beads (IBA lifesciences - Germany) using overexpressing cells 
processed as outlined in the producer’s standard protocol. 
!
kDNA decatenation assays 
Nuclear extracts of murine ﬁbroblasts were prepared from 100 mm conﬂuent petri 
dishes. Cells were scraped into medium and pelleted at 800g for 3 minutes at 4°C. The 
cellular pellet obtained was then resuspended in 5 ml of ice cold TEMP buﬀer (10 mM 
Tris-HCl, pH 7,5, 1 mM EDTA, 4 mM MgCl2, 0,5 mM PMSF) and the clump dispersed by 
pipetting. After an incubation of 10 minutes on ice and additional centrifugation step, 
the pellet obtained was resuspended in 20μl of TEP buﬀer (same as TEMP but lacking 
MgCl2 ). 20μl of NaCl 1M were thus added to the resuspension and the mix was 
incubated for 1 hr on ice. After an additional centrifugation step of 15 minutes at 16000 
g, 5μl of supernatant were employed for the decatenation assay. 
The reaction mix consisted of 0.1 ug KDNA (ﬁnal volume of 20ul), 50 mM Tris-HCl (pH 8), 
120 mM KCl, 10 mM MgCl2, 0,5 mM each of DTT and ATP and 30 ug BSA/ml (topo II 
reaction buﬀer TG4040).  
The reactions were incubated for 15 min at 37o C and terminated with 0,1 volumes of 
stop buﬀer (5% sarkosyl, 0.025% bromophenol blue, 50% glycerol). Half of the mixture 
was then loaded on a 1% agarose gel and the result visualized under UV light. 
!
Antibodies 
Antibodies used in this work included:monoclonal α-actin (Sigma Aldrich A5441); 
polyclonal α-53BP1 (Novus 100-304A2); polyclonal α-MUS81 (a kind gift of R. Hakem, 
Ontario Cancer Institute); polyclonal α-NSMCE2/MMS21 (self raised); monoclonal α-BrdU 
(Millipore); monoclonal α-STREPT-tag (Novagen); α-FLAG M2 (Sigma-Aldrich); polyclonal 
α-SMC5 (Santa Cruz Biotechnologies, Santa Cruz, CA); polyclonal α-hSMC6 (kindly 
provided by A. Lehmann, University of Sussex); monoclonal α-ER (CNIO monoclonal 
antibody unit); monoclonal α-TopII (Topogen). 
"45
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
 Results – part I   
Results - part I
Results - part I 
A role for NSMCE2-dependent SUMOylation in the activity of the SMC5/6 in 
metazoans 
Generation of mouse models for Nsmce2 - preliminary validation 
When starting this project, we met with a ﬁrst issue to overcome: the lack of mouse 
models for Nsmce2.  
As a ﬁrst tentative approach, a gene trapped Nsmce2GT/GT mouse strain was generated in 
the lab (Jacome et al. unpublished), which resulted being early embryonic lethal in 
homozygosis, recapitulating the lethality observed in mms21Δ yeast cells (Giaever, Chu et 
al. 2002). 
Alternatively, we decided to follow the lead of yeast literature and looked for solutions to 
impair the function of NSMCE2 avoiding the early lethality. A mutant strain was thus 
generated, bearing two mis-sense point mutations reported, in the S. pombe, to impair the 
SUMO E3 ligase activity of Nse2 (Andrews, Palecek et al. 2005). The transgenesis strategy 
employed is depicted in ﬁgure 10. 
Figure 10: Targeting strategy for the generation of the Nsmce2SD strain. The C185S; H187A mutation was 
inserted into exon 6 by a recombination vector bearing Ex.6 and carrying an FRT-neoR cassette. The mouse 
strain we employed carried the neo+ allele. 
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As outlined in Duan, Sarangi et al. 2009, two key Cys and His residues, located at the 
conserved catalytic core of the SP-RING domain of NSMCE2 and presenting a striking 
evolutionary conservation, were mutated to Ser and Ala respectively (ﬁgure 11). 
Figure 11: the SP-RING catalytic core is highly conserved throughout evolution. The two Cys and His 
residues mutated in the SUMO-dead strain reside in the active site of the SP-RING domain of NSMCE2. Their 
functional relevance is corroborated by their striking conservation throughout evolution and among other 
SUMO ligases such as PIAS4 and PIAS1-Siz1.  The two residues provide the coordination site for the binding 
of Zn2+, a fundamental cofactor in the catalysis of SUMO conjugation.  
In order to prove the validity of our strategy, we cloned the Nsmce2WT and the SUMO-
dead (SD) version of Nsmce2 (Nsmce2SD) from RNA extracts obtained from our mouse 
model.  
We then overexpressed both the NSMCE2SD and the NSMCE2WT proteins in 293T cells, 
together with tagged versions of either SUMO1 or SUMO2, performed 
immunoprecipitations against the tags employed and veriﬁed the reported auto-
SUMOylation of NSMCE2 as a functional readout of the SUMO ligase activity of the 
protein (Andrews, Palecek et al. 2005; Zhao and Blobel, 2005). 
As in ﬁgure 12, NSMCE2 is able to conjugate both SUMO1 and SUMO2 upon 
overexpression. 
!
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Figure 12: the C185S; H187A substitutions impair the SUMO2 ligase activity of NSMCE2 in vitro. The 
experimental strategy followed is outlined. (A) We cloned the cDNA of NSMCE2 (either in its wild-type or 
SUMO-dead versions) in a mammalian expression vector. Stable expressing cell lines for both variants were 
thus generated. (B) We overexpressed in NSMCE2-cells either SUMO1 or SUMO2, with a GFP or a FLAG tag, 
respectively. After performing IPs against either of the tags, we detect the auto-SUMOylated form of NSMCE2 
by WB. 
Whilst the SUMO-dead mutations negatively aﬀected the protein activity towards SUMO1, 
it virtually abrogated its SUMO2 ligase catalysis. (ﬁgure 12 - B). 
It is worth underlining how these experiments were performed by overexpressing both 
the mutated and the wt murine proteins in a context where human NSMCE2WT was 
expressed at physiological levels. It remains thus possible that the partial activity 
observed with SUMO1 could be attributed to the activity of the endogenous protein.  
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Strategies to deﬁne the NSMCE2-associated SUMOylome. 
A ﬁrst goal of our work was to deﬁne the NSMCE2-associated SUMOylome. Despite the 
presence of only few E3 conjugating enzymes in metazoans, at today’s date a global 
characterization of the proteome fraction speciﬁcally modiﬁed by NSMCE2 is indeed still 
missing, and only few targets of the proteins have been described (Pebernard, 
Wohlschlegel et al. 2006; Potts and Yu, 2005; Zhao and Blobel, 2005). Our attempt aimed 
at broadening our perspective on the physiological role of NSMCE2, so to narrow our 
attention on a list of protein candidates for further functional characterization. As 
outlined in ﬁgure 13, we generated several diﬀerent tagged versions of SUMO1 and 2. 
All clones were inserted in a third-generation lentiviral vector that allowed for antibiotic 
selection (blasticidin) as well as for GFP-expression enrichment via cell sorting. 
Figure 13: SUMO overexpression strategies designed to deﬁne the NSMCE2 associated SUMOylome. 
The murine sequences of SUMO1 and SUMO2 were cloned downstream a 6XHIS tag, a 6XHIs-FLAG/
6XHis-3XFLAG or a streptavidin tag into a third-generation lentiviral vector allowing for antibiotic selection 
and ﬂuorescence-mediated sorting. 
We transduced SV40T121- immortalized MEFs obtained from Nsmce2SD and wt embryos, as 
in the pipeline diagram of ﬁgure 14. 
Figure 14: Experimental pipeline for SUMOs overexpression in murine ﬁbroblasts. MEFs from the 
SUMO-dead and WT control strains were immortalized with SV40T121. After immortalization and drug-
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mediated selection of infected cells, these were transduced with one of the diﬀerent tagged versions of 
SUMOs. Blast and puro/hygro-resistant cells were then sorted to enrich for the top 10% expressors. 
The diﬀerent tagging strategies notwithstanding (and despite the varied puriﬁcation 
methodologies employed), we typically encountered the problem of boosting the SUMO 
levels in murine ﬁbroblasts, a cell type that is often refractory to exogenous protein 
overexpression (Palmer, Rosman et al. 1991).  
Additionally, we noticed a negative eﬀect on cell viability, presumably due to free SUMOs 
over-expression. This detrimental eﬀect has indeed been reported in diﬀerent model 
systems (Rytinki, Finland et al. 2013) underlining how a tight control of SUMO levels is 
fundamental for cellular homeostasis (Bawa-Khalfe and Yeh 2010). Figure 15 illustrates 
the typical outcome of a puriﬁcation experiment, aimed at enriching for the STREPT-
conjugated fraction of the proteome. 
Figure 15: Experimental pipeline to purify and enrich the NSMCE2 associated SUMOylome. (A) 
Immortalized Nsmce2SD or wt MEFs were transduced with a STREPT-tagged version of SUMO2 or its relevant 
control. After drug selection and GFP-mediated expression enrichment, they were transiently electrofected 
with either a WT or a DN form of FLAG-UBC9, the SUMO E2 conjugating enzyme (panel B). (C) Despite the 
GFP-mediated enrichment, free SUMO2 was virtually undetectable in MEFs total lysates. 
In conclusion, despite having conﬁrmed the eﬀective ligase activity impairment for 
NSMCE2SD in vitro, we were unable to provide a systematic description of NSMCE2 
targets in mammalian cells with the strategy undertaken. Additional possibilities are 
indeed conceivable to address the issue. As an example, recent developments have 
resulted in optimized antibody-mediated puriﬁcation strategies to detect endogenous 
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SUMO targets (Becker, Barysch et al. 2013). Alternatively, novel molecular modiﬁcations 
of endogenous SUMO proteins have allowed to provide a high resolution 
characterization of global SUMOylation in cells (Galisson, Mahrouche et al. 2011).  
We nevertheless continued focusing our attention on the functional implication of such 
mutation, rather than on its biochemistry.  
SUMO-dead cells show a genomic instability signature. 
As previously mentioned, yeast cells carrying SUMO ligase-abrogating mutations in 
mms21/nse2 show increased sensitivity to DNA cross-linking and UV irradiation, as well as 
a general chromosomal instability that commonly leads to gross genomic aberrancies 
(Bermudez-Lopez, Ceschia et al. 2010; Chen, Choi et al. 2009; Maria, Gangavarapu et al. 
2007).  
We tested for the presence of the same features in MEFs derived from SUMO-dead mice, 
and quantiﬁed their tendency to accumulate micronuclei and form polynucleated cells, 
either spontaneously or after the induction of DNA damage by MMS.  
We devised such approach since micronucleation and polynucleation represent the 
pleiotropic outcome of diﬀerent issues encountered by cells during replication or 
segregation - among which the accumulation of joint DNA molecules.  
We observed that Nsmce2SD MEFs accumulated micronuclei spontaneously (ﬁgure 16–A) 
and that they generated bi-nucleated and polynucleated cells, possibly after aborting 
anaphase (ﬁgure 16–B).  
Importantly, these phenotypes were in agreement with what observed after the 
impairment of dissolution, as in the case of BLM/Sgs1 mutant cells.  
To further verify the dependency of these phenotypes on the amount of joint DNA 
molecules arising in replicating cells, we challenged replication by treating MEFs with 
MMS, failing to observe a proportional tendency to micro-nucleation or poly-nucleation in 
Nsmce2SD cells after treatment. We reasoned that such result could probably be due to a 
negative eﬀect of the drug on cell proliferation, which consequently impeded the 
accumulation of replication-related by-products. 
!
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Figure 16: Nsmce2SD cells spontaneously accumulate micronuclei and show polynucleation. 
Micronuclei accumulation and polynucleation was scored in SUMO-dead cells and wt counterparts (panel A 
and B, respectively). Sample pictures of scored events are represented on the right. Scale bar: 10µM. 
To rule out that the SUMO-dead mutation might impair the assembly of the SMC5/6 
complex, as well as alter the functionality of NSMCE2, we conﬁrmed the preservation of 
the association between SMC5, SMC6 and NSMCE2WT or SD by immunoprecipitation and 
the ability of either NSMCE2SD and NSMCE2WT to form foci in vitro (ﬁgure 17-A and B). 
!
!
!
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Figure 17: The SUMO-dead mutation doesn’t alter the composition of the SMC5/6 complex nor aﬀect 
NSCME2 foci formation in vitro. The SUMO-dead variant of NSMCE2 assembles in the SMC5/6 comparably 
to the WT counterpart, and is similarly able to form foci in vitro upon MMS treatment (10mM). Scale bar = 10 
μm (courtesy of A. Jacome).  
To further corroborate the genomic instability signature observed in ﬁbroblasts, we 
shifted our attention to B lymphocytes and quantiﬁed the rates of sister chromatid 
exchanges (SCE) at mitosis, another major feature of BLM/Sgs1 mutant cells, as well as 
their tendency to spontaneous micronucleation and polynucleation. 
We could indeed observe a signiﬁcant increase of SCEs in Nsmce2SD B-cells, compared to 
their wild-type counterparts (ﬁgure 18), recapitulating, even if to a lesser extent, both the 
typical cellular hallmark of the Bloom syndrome (Chaganti, Schonberg et al. 1974) and 
the higher recombination rates observed for yeast mms21 mutants (Prakash and 
Prakash 1977). 
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Figure 18: lymphocytes from Nsmce2SD animals show increased SCE rates. Representative image of 
splenic B cells, obtained from WT or SUMO-dead animals and scored for the rate of SCEs upon nocodazole 
treatment. Scale bar: 15µm. The dot plot shows the quantiﬁcation of SCE events/metaphases encountered in 
the samples. 
An intriguing hypothesis: NSMCE2 regulating topoisomerases activity? 
Intriguingly, the increased recombination rates we observed Nsmce2SD cells reminded of 
some of the phenotypes associated to the impairment of topoisomerases (Kegel, Betts-
Lindroos et al. 2011; Olaharski, Mondrala et al. 2005). These enzymes prevent the 
intertwining that aﬀects homologue DNA strands at the convergence of opposite 
replication forks, and they play an essential role in dealing with replication 
intermediates. As discussed earlier, in order to exert its function, BLM depends, in fact, 
on the physical interaction with topoisomerase IIIα (Hu, Beresten et al. 2001).  
Both in yeasts and metazoans, mutations aﬀecting topoisomerases are commonly 
associated to genomic instability (Bower, Karaca et al. 2010). Among the four subtypes 
encoded in the genome, class II topoisomerases play a pivotal role in mediating the 
disentanglement of joint DNA molecules before the onset of anaphase. By means of 
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several post-translational modiﬁcations, their activity is ﬁnely orchestrated with the 
replication machinery, and in such context SUMOylation exerts a fundamental function. 
(Ryu, Furuta et al. 2010). A possible NSMCE2-mediated regulation of topoisomerase 
activity hasn’t so far been reported, but some literature underlines a genetic interplay 
between topoisomerases and the SMC5/6 complex (Harvey, Sheedy et al. 2004; Tapia-
Alveal, Outwin et al. 2013). In order to investigate a possible role NSMCE2 in the 
regulation of topoisomerases, we took advantage of an in vitro DNA decatenation assay, 
allowing to probe for the activity of topoisomerase IIα. The results outlined in ﬁgure 19 
led us to conclude that, at least for the in vitro activity of topoisomerase IIα, the SUMO-
ligase activity of NSMCE2 is dispensable. 
Figure 19: NSMCE2 mediated SUMOylation doesn’t aﬀect TopIIα activity. (A) TOPO activity was assayed 
in vitro by means of a kDNA disentanglement assay. (as in Material and Methods). (B) Puriﬁed nuclear 
extracts from wild-type and SUMO-dead cells were assayed for the levels of TopII α by WB. (C) TopIIα from 
both cell types can proﬁciently decatenate kDNA molecules. 
Our observations didn’t rule out, though, other possible regulations operated by the 
SMC5/6 complex in relation to topoisomerases. The complex may help targeting 
topoisomerases to their site of action, as an example. The budding yeast Smc5/6 
complex was shown to localize to centromeres, telomeres and the chromosome arm 
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that harbours the ribosomal DNA arrays. All these are regions which are intrinsically 
prone to replication issues (Lindroos, Strom et al. 2006; Torres-Rosell 2005). Alternatively, 
other subtypes of topoisomerases could be the target of the SUMO regulation 
potentially operated by NSMCE2 (Kegel, Betts-Lindroos et al. 2011). 
SUMO-dead animals show hallmarks of genomic instability 
To investigate the consequences of NSMCE2 SUMO ligase deﬁciency in vivo, we tested 
our Nsmce2SD mice for the presence of a genomic instability signature at the tissue level. 
We ﬁrst narrowed our search on the liver, a tissue that is particularly tolerant towards 
genomic aberrancies, and scored for the presence of either micronucleated or 
polynucleated cells in paraﬃn-embedded sections of the organ.  
As reported in ﬁgure 20, Nsmce2SD animals accumulated more micronucleated and 
polynucleated cells than both their wild-type and Nsmce2+/KO heterozygous counterparts. 
Figure 20: Nsmce2SD animals show a systemic genomic instability signature.  Stained liver sections were 
analyzed for cells presenting polynucleation or accumulation of micronuclei. Nsmce2SD mice showed a 
divergent tendency to such accumulations when compared to controls. For every quantiﬁcation, samples 
from n=4 animals were used.   
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To get further in vivo insights on the genetic similarity between NSMCE2 and BLM 
mutations, we decided to verify another typical hallmark of Bloom syndrome in our 
model. Blm mutations promote the insurgence of tumours and colon cancer is the most 
common single solid tumour in Bloom carriers (German, J. and Ellis, N. A. 2002). We 
interrogated our NSMCE2SD mouse model for the same tendency and performed an 
azoxymethane-dextran sulphate (AOM-DSS) induced carcinogenesis assay on a cohort of 
wild-type and mutant mice, following the methodology reported in Nambiar, Girnun et al. 
2003.  
We could highlight a modest, albeit statistically signiﬁcant increase in the number of 
small-sized colon tumours in NSMCE2SD animals (ﬁgure 21), conﬁrming our preliminary 
hypothesis and providing evidence supporting a “tumour protection” role for Nsmce2, at 
least in our experimental conditions. 
Figure 21: Nsmce2SD animals are prone to tumour formation. (A) Representative image of paraﬃn-
embedded sections of colon samples from Nsmce2wt and SUMO-dead animals. A sample of scored tumours is 
circled in yellow. Scale bar = 200 µm. (B) SUMO-dead mice showed an increased tendency to develop colon 
tumours, recapitulating in vivo what observed in Bloom patients. 
"58
A B
Results - part I
The Nsmce2SD mutation doesn’t aﬀect ﬁtness and brings about a mild phenotype 
In order to further evaluate the physiological eﬀect the Nsmce2SD mutation, we analyzed 
the overall phenotype of animals and setup ageing curves of mutant animals against 
wild-type controls. 
Nsmce2SD animals were breeding normally and were undistinguishable from wild-type 
counterparts in terms or size and weight. (ﬁgure 22-A)  
Unexpectedly, the mutation didn’t aﬀect the overall ﬁtness of the SUMO-dead animals, as 
reported by the Kaplan – Meier curve in ﬁgure 22-B. 
Figure 22: the Nsmce2SD mutation doesn’t aﬀect ﬁtness. Animals bearing the Nsmce2SD mutation  in 
homozygosis were undistinguishable from their WT counterparts. (panel A). We monitored a cohort of 
SUMO-dead animals/ (n= 35) and wild type controls (n=39) during roughly 3 years. The survival curve of 
Nsmce2SD animals didn’t diverge signiﬁcantly from that of wild-type controls (panel B). 
Their survival rate didn’t indeed deviate from that of wild type animals, as well as the 
incidence of spontaneous tumours in these animals (not shown). 
The mild phenotype of our SUMO-dead mouse model was unexpected. Despite the lack 
of a negative eﬀect of survival, our observations in vitro (the increased rate of SCEs at 
mitosis, the increased proportion of micro nucleation and and polynucleation) as well as 
some in vivo hints (a mild accumulation of micronucleated and polynucleated cells in 
tissues, together with the increased tumorigenesis) recapitulated previous observations 
made in cells from Bloom patients. 
Given the observed phenotypes, we decided to extend our analysis of the Nsmce2SD allele 
in mice by investigating its genetic interaction with the resolution pathway.  
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A genetic approach to frame the SMC5/6 complex in dissolution 
Intercross of SUMO-dead animals with a Mus81KO strain 
As mentioned, Nsmce2SD mice bear some of features typically associated with genomic 
instability, at least at the cellular level. Considering that the observed phenotypes 
overlapped with what described for Blm mutants, we reasoned that a classical genetic 
approach might help elucidate the  functional role of the SMC5/6 complex in dissolution. 
In order to test such hypothesis, we decided to take advantage of mouse models for 
resolution described in the literature. 
A ﬁrst available candidate was the Mus81 knock-out mouse reported in McPherson, 
Lemmers et al. 2004. We rederived the strain on our mixed-background line, verifying at 
ﬁrst the actual deﬁciency of the protein by Western blot. (ﬁgure 23 - A)  
"  
Figure 23: Mus81KO animals show a genomic instability signature. (A) We could conﬁrm the actual 
deletion of MUS81 in rederived animals by Western blot on testis protein samples. (B) A reported feature of 
Mus81KO cells is a mild sensitivity to MMC. T-lymphocytes from Mus81KO animals exposed to the drug 
accumulate chromosomal aberrancies as the ones highlighted by white arrows (adapted from McPherson, 
Lemmers et al. 2004) 
Interestingly, the Mus81KO strain we used was reported to show haplosuﬃcient tumour 
suppression, which reﬂected in the survival rates of animals (ﬁgure 24-A). This striking 
result is in contrast with what observed in an alternative Mus81-null strain (Dendouga, 
Gao et al. 2005), which instead lacked any major phenotype (ﬁgure 24-B), and such 
"60
A B
Results - part I
important contradiction warned us on the possibility of a background-related eﬀect for 
the mutation.  
Despite the remarkable survival discrepancy, both models concurred on a mild 
sensitivity to agents such as MMC, UV irradiation and MMS, as in ﬁgure 25. 
!
Figure 24: discrepancies between Mus81KO models available. The two Mus81-null strains reported in the 
literature show a strikingly contradictory diﬀerence in terms of survival.(A) KM survival curve for the Mus81KO 
model used in our study.(B) KM survival curve from the alternative Mus81 model (McPherson et al. 2004; 
Dendouga et al. 2005). 
"  
Figure 25: all Mus81KO strains show comparable sensitivity to DNA damaging agents. Both Mus81KO 
models respond consistently to DNA damaging drugs as highlighted by SCE experiments (A – McPherson et 
al. 2004) or metaphase spreads from B-cells (B – Dendouga et al. 2005) 
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Our ﬁrst experimental approach aimed at verifying the outcome of impairing genetically 
both the resolution and the dissolution of DNA joint molecules, contemporarily. 
Numerous reports, as previously mentioned, show the lethal outcome of this genetic 
combination in lower eukaryotes. According to what ﬁrst observed in yeast (Kaliraman, 
Mullen et al. 2001), mus81 and mms4 are also synthetic lethal with null mutations in 
mus309, which encodes the orthologue of the Bloom syndrome helicase in Drosophila 
(Trowbridge, McKim et al. 2007).  
A possibility we consequently envisaged from our experimental setup was synthetic 
sickness: the inability to cope with replication intermediates would lead to the 
accumulation of joint DNA species and result in increased genomic instability, especially 
in organs and tissues with a sustained cellular turnover and high rates of cellular 
replication. 
We thus continued by crossing our Nsmce2SD animals onto the rederived Mus81KO strain, 
deﬁning a genetic scenario by which both resolution and dissolution (considering the 
genetic equivalence Nsmce2 = Blm we postulated) would be aﬀected. 
The Nsmce2SD: Mus81KO mutations are not synergic in cells. 
The dissection of the possible genetic interaction between Mus81 and Nsmce2 followed a 
“simple to complex” approach. We started with experiments on MEFs derived from the 
Mus81KO strain, reasoning that the outcome of impairing resolution could be a feedback 
up-regulation of the dissolution pathway, following a trend commonly observed in 
biological systems (Kitano 2004).  
As a proof of principle, we quantiﬁed the accumulation of NSMCE2 foci in Mus81KO cells, 
which could indicate an accumulation of joint DNA species demanding the activity of the 
SMC5/6 complex, as previously reported in our lab (unpublished data). We therefore 
performed NSMCE2 immunoﬂuorescence stainings on Mus81KO and wild-type cells, after 
treating them with a sublethal dose of MMS. As shown in ﬁgure 26, NSMCE2 did 
aggregate into bigger and more intensely stained foci upon the treatment with MMS, but 
no marked diﬀerence between the two lines could be emphasized.  
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Figure 26: NSMCE2 foci formation is unaﬀected by MUS81 depletion. Primary ﬁbroblasts from Mus81KO 
animals and wild-type controls were treated with MMS and and stained for NSMCE2/Mms21. Upon 
treatment, a similar accumulation of NSMCE2 foci was observed in both samples. Scale bar: 15µm. 
These ﬁrst negative observations don’t rule out a possible functional interaction 
between NSMCE2 and MUS81. For that reason we sought additional evidence from the 
Nsmce2SD : Mus81KO double mutant model we had just generated.  
As a ﬁrst step, we veriﬁed that the protein levels of NSMCE2 wouldn’t be aﬀected by the 
deletion of Mus81 (ﬁgure 27). 
"  
Figure 27: NSMCE2 levels are unaltered after the deletion of Mus81 in cells. Cells from wild-type, 
Nsmce2SD : Mus81KO and relevant single-mutated controls were genotyped and blotted for NSMCE2. The 
levels of the protein were comparable to the wild-type controls in all genetic contexts. 
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We then proceeded along the line with what done for the Nsmce2SD model, and 
monitored the accumulation of micronuclei and polynucleation in MEFs obtained from 
Nsmce2SD : Mus81KO animals (and relevant controls). 
As depicted in ﬁgure 28, double-mutant cells treated with increasing concentrations of 
MMS didn’t respond diﬀerently from controls. We noticed a trend in the accumulation of 
micronuclei that followed the increasing doses of MMS treatment (at least in the case of 
wild-type cells) but in the other genetic backgrounds, the situation wasn’t quite as 
deﬁned.  
Figure 28: Nsmce2SD:Mus81KO show similar micronuclei accumulation as their control counterparts. 
When scoring for micronuclei accumulation in the double mutant cell subtype, we couldn’t highlight a 
negative synergy between mutated Nsmce2 and Mus81. 
Mus81KO cells, expectedly, accumulated less micronuclei than their counterparts, due to 
their sensitivity to MMS, an alkylating agent reported to impair cell proliferation at the 
concentrations we employed. (McPherson, Lemmers et al. 2004) 
Double mutants behaved accordingly to what observed in the single mutants, inheriting 
the characteristics of both Nsmce2SD and Mus81KO alleles. They showed a basal tendency 
to instability, though such tendency couldn’t be exacerbated by MMS treatment, 
probably because of the proliferation arrest driven by the absence of MUS81 in the 
presence of MMS, as previously reported (McPherson, Lemmers et al. 2004).  
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The quantiﬁcation of polynucleated cells provided a similar outcome (ﬁgure 29): the 
basal levels of polynucleation in single mutants and double mutants were higher than wild-
type controls, but the negative eﬀect on proliferation impeded to highlight any 
incremental eﬀect at increasing concentrations of the drug. The double-mutants, 
moreover, didn’t show a worsened response than the single mutants alone.  
Figure 29: Nsmce2SD:Mus81KO cells tend to polynucleation spontaneously, similarly to  single mutant 
controls. When scoring the polynucleation rates of single mutants and double mutant cells, we noticed a 
positive trend, but no direct correlation with the concentration of MMS used to induce damage. 
To gain further insights into the DNA damage response of Nsmce2-Mus81 double mutant 
cells, we analyzed the accumulation of nuclear 53BP1 foci upon treatment with 
damaging agents (such as MMC and MMS).  
We envisioned that the depletion of MUS81 in a NSMCE2SD background - hence, in a 
context of accumulation of joint DNA molecules  - could result in the breakage of 
unprocessed recombination intermediates at cell division. Consequently, the rupture of 
intertwined DNA molecules would promote DNA repair and the accumulation of 53BP1 
at the site of breaks. We thus interrogated MEFs from our murine model for their 
propensity to accumulate 53BP1 foci, comparing double Nsmce2SD - Mus81KO mutants 
with their controls. In order to increase the accumulation of replication intermediates, 
we induced the collapse of replication forks by treating cells with increasing 
concentrations of MMC and a sublethal dose of MMS. The results outlined in ﬁgure 30-A 
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highlight how double mutant cells show an accumulation of 53BP1 foci comparable to 
that of single Mus81KO and Nscmce2SD mutants, at diﬀerent MMC concentrations. 
Interestingly, the number of foci in both single and double mutant cells deviated from 
that of wt controls, suggesting, indirectly, the actual accumulation of broken DNA 
replication intermediates in these cells. As in the case of micro-nucleation and 
polynucleation though, no marked negative synergy could be detected. 
Figure 30: Nsmce2SD-Mus81KO cells show an unaltered response to DNA damage upon the induction of 
replication stress. (A) 53BP1 foci were quantiﬁed by HT microscopy after the induction of replication stress 
(by means of MMC and MMS treatment) on double mutant cells and relevant controls. (B) Representative 
image of the induction of gH2AX and 53BP1 foci in cells upon treatment with MMC. Scale bar = 15 μm. (C) 
The accumulation of pan-nuclear gH2AX foci in cells (an established readout of replication stress) didn’t 
diﬀer markedly among the diﬀerent lines. 
Finally, we checked for the accumulation of chromosomal abnormalities in double 
Nsmce2SD-Mus81KO cells and controls. Whereas we could detect the presence of aberrant 
chromosomal ﬁgures (such as radials, also commonly found in Blm cells, as in ﬁgure 31 - 
circled in red) we didn’t encounter a statistically signiﬁcant diﬀerence between wt cells, 
Nsmce2SD, Mus81KO or the double Nsmce2SD- Mus81KO samples. 
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Figure 31: the Nsmce2SD-Mus81KO mutations do not result in aberrant metaphases in MEFs. Metaphase 
spreads were prepared from wild type, Nsmce2SD, Mus81KO and Nsmce2SD-Mus81KO cells, after treatment with 
either MMS or MMC, and chromosomal aberrancies were sought for (blue arrows). Though no striking 
eﬀects were noticeable after MMS treatment, we highlighted the presence of radial chromosomes in MMC 
treated Nsmce2SD-Mus81KO cells. 
Compensatory eﬀects of Gen1-Slx1/4 in Nsmce2SD:Mus81KO cells? 
It is possible that the lack of a clear phenotype in our cells could be due to 
compensatory pathways. The plausible functional redundancy of SLX1/SLX4 and GEN1 in 
mediating resolution could indeed counterbalance the absence of MUS81.  
In order to shed a light on such possibility, we silenced, using RNAi, Slx4 and Gen1, with 
the aim of impairing resolution of joint DNA molecules signiﬁcantly.  
Our experimental approach is summarized in ﬁgure 32. 
!
!
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Figure 32: experimental strategy to impair resolution in Nsmce2SD-Mus81KO cells.(A) We used a lentiviral 
based platform to selectively silence Slx4 and Gen1 in double homozygous cells and controls with a 
commercially validated shRNA sequence. (B) After transduction and antibiotic selection, we measured the 
silencing of shRNA targets by RT-PCR, verifying their partial eﬃcacy. 
After transducing MEFs from our double mutant line and control strains with shRNAs 
against Gen1 and Slx4, we selected infected cells by adding puromycin to the culture 
medium.  
Additionally, we immortalized them by infecting puromycin-selected pools with a 
retrovirally encoded SV40T121, in order to overcome the possible replicative arrest of 
MEFs after transductions. 
We tested for the eﬃcacy of the shRNA mediated silencing by measuring the RNA levels 
of Gen1 and Slx4 in our treated cells (ﬁgure 32-B), verifying how only a partial knock-down 
of nucleases could be attained.  Despite the mild silencing, we established growth curves 
of shRNA treated MEFs, either primary or T121 immortalized, to verify if the partial 
silencing of resolution nucleases could nevertheless result in impaired growth in a 
Nsmce2SD-Mus81KO genetic background. 
As in ﬁgure 33, all cell types responded aspeciﬁcally to the RNAi procedures, mostly by 
arresting proliferation (particularly in the case of Gen1 silencing). The same result was 
recapitulated when we tested both primary and immortalized MEFs for EdU 
incorporation (ﬁgure 34) Both the extensive manipulation and the partial functionality of 
the shRNAs employed (as well as plausible oﬀ-targeting eﬀects of the shRNA employed) 
led to important eﬀects on cell proliferation, jeopardizing the possibility of using this 
setup as an experimental platform. 
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Figure 33: the shRNA mediated silencing of endonucleases impairs cells proliferation aspeciﬁcally- 
#1. Primary MEFs treated with shRNAs for Slx4, Gen1 (or an empty control) tend to reduce their proliferation 
rate and enter proliferative arrest. Immortalization through SV40-T121recovers partially the phenomenon. 
Figure 34: the shRNA mediated silencing of endonucleases impairs cells proliferation aspeciﬁcally - 
#2. Cells treated with shRNAs against resolution nucleases incorporate less EdU than controls. The negative 
eﬀects on proliferation of shRNA treatments, conﬁrmed by EdU incorporation experiments in primary MEFs 
(A), could only partially be recovered by SV40T121 immortalization (B). 
Nsmce2SD – Mus81KO animals don’t diﬀer signiﬁcantly from control strains. 
Despite the lack of a clear phenotype in MEFs, which suggested the lack of a synergic 
interaction between Mus81 and Nsmce2, we analyzed the impact of the elimination of 
MUS81 on the Nsmce2SD background in vivo. We hence focused on the Nsmce2SD-Mus81KO 
mice and setup ageing curves of  double homozygous animals and relevant controls. At 
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the same time, we arranged for heterozygous crosses of double heterozygous mice, in 
order to verify the transmission of the Mus81KO and the Nsmce2SD alleles. As depicted in 
ﬁgure 35, no remarkable general diﬀerences between control animals and Nsmce2SD - 
Mus81KO double homozygous could be highlighted. Mice had a similar average weight, 
and their size wasn’t signiﬁcantly altered. The coexistence of both mutations, moreover, 
didn’t aﬀect the animals’ ﬁtness, since they survived as well as controls and bred 
normally. Finally, the allelic transmission of both mutant genes followed an expected 
Mendelian pattern, stressing the non-synergic eﬀect of the two mutations, and the lack 
of synthetic sickness, despite our expectancy. 
"  
Figure 35: Nsmce2SD: Mus81KO animals show no peculiar diﬀerences from control cohorts. Neither their 
average weight nor size (as in A and B) was aﬀected by the mutated alleles. (C) Animals survival rates where 
comparable, and the Nsmce2/Mus81 alleles were transmitted at expected Mendelian ratios (D). 
The normal phenotype arising from the genetic combination Nsmce2SD - Mus81KO came 
only partially as a surprise. On one side, our major concern was the lack of major 
consequences upon the depletion of MUS81, which is at odds with the striking 
phenotypes reported for the Mus81KO model we employed (McPherson, Lemmers et al. 
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2004). On the other side, though, the absence of a negative synergy between the two 
alleles further corroborated our observations on the mild phenotype presented by the 
Nsmce2SD strain.  
These results prompted us to explore the involvement of the SMC5/6 complex in 
dissolution using other mutant strains of SMC5/6. 
Smc6S994A as an alternative genetic carrier. 
As introduced previously, a major issue to study the SMC5/6 complex in mammals was 
the lack of appropriate murine working models. Taking in consideration the poor 
phenotype of Nsmce2SD in vivo, we opted for a recently characterized mutant for the 
SMC5/6 complex, presenting a stronger phenotype. 
The strain bears a point mutation in Smc6 (Smc6S994A-neo) ( Ju, Wing et al. 2013) that 
recapitulates a separation of function mutation (smc6-S1045A) shown to confer 
increased genomic instability in S. pombe ( Jessberger 2002) . It’s to be underlined again 
how Smc6 is an essential gene, both in yeast and metazoans (Ju et al. 2013) and that the 
outcomes of the Smc6S994A-neo mutation (an increased rate of SCE at mitosis and sensitivity 
to replication-challenging agents) phenocopy what observed in the case of several mms21 
mutants and functional equivalents (Doe, Murray et al. 1993; Lehmann, Walicka et al. 
1995; Verkade, Bugg et al. 1999). 
Apart from their genomic instability phenotype , Smc6S994A-neo homozygous animals are 
remarkably smaller in size, when compared to heterozygous and wt counterparts. 
This allelic option represented hence a better experimental scenario for our purposes. 
By taking advantage of the Smc6S994A-neo strain, we could employ a mutant for the SMC5/6 
showing similar in vitro features as Nsmce2 mutants and possessing, moreover, a more 
evident and easily characterizable phenotype. 
For this reason we rederived the strain on our mixed background and veriﬁed the 
preservation of the size anomaly reported for the model (ﬁgure 36). 
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Figure 36: Smc6S994A-neo animals are smaller than wt counterparts. We rederived the Smc6S994A-neo 
mutation onto our mixed genetic background and veriﬁed the reduced size phenotype. The body size 
diﬀerence between adult (14 weeks) Smc6S994A-neo animals and wt reﬂected their average weight diﬀerence. 
According to the strategy outlined for the Nsmce2SD strain, we crossed the new line with 
Mus81KO animals, and, similarly to the previous case, established matings of 
heterozygous animals to verify the allelic transmission, as well as ageing curves of 
double homozygous mice and relevant controls. Strikingly, we encountered a strong 
synthetic lethality between Smc6S994A-neo and Mus81KO. We weren’t indeed able to obtain 
neither double homozygous Smc6S994A-neo: Mus81KO animals out of the litters born of our 
experimental crosses (ﬁgure 37) nor double homozygous embryos, at least up to E10.5 
(data not shown). 
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Figure 37: Smc6S994A-neo and Mus81KO are synthetic lethal in mice. The allelic transmission of Mus81KO and 
Smc6S994A-neo is non Mendelian. The same result was conﬁrmed by the genotyping of embryos up to E10.5 
(data not shown). 
This striking result represented an obvious major drawback, for the impossibility to 
obtain animals or cells for experimental purposes. Interestingly though, despite the 
need for further characterization, the outcome of the Smc6S994A-neo: Mus81KO intercross 
was  supporting the hypothesis that impairing resolution on an "impaired SMC5/6 
background" might severely aﬀect ﬁtness. 
In order to overcome this issue, we devised to reproduce the same genetic combination 
by employing a Gen1KO strain we recently obtained (Matthews et al. unpublished) as an 
alternative strategy to aﬀect resolution. 
The Gen1KO mice we employed have no major phenotype, showing a normal lifespan and 
breeding normally (Matthews et al. unpublished). Our new endeavour was frustrated, 
though, by the localization of Gen1 and Smc6 in the murine genome. Both genes co-
localize on the same arm of chromosome 12 (ﬁgure 38) and their genetic linkage 
hinders their independent segregation, hence hampering the possibility of performing 
classical genetic analysis. We nevertheless believe that this  ﬁnding is probably indicative 
of a functional relationship GEN1 - SMC5/6 complex. 
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Figure 38: Smc6 and Gen1 show genetic linkage. We checked the localization of Gen1 and Smc6 in the 
murine genome through the ENSEMBL genome navigator (Flicek, Ahmed et al. 2013) verifying their close 
proximity, hence the impossibility to study their independent segregation. Intriguingly, this genetic linkage 
might suggest a potential genetic and functional interplay, as observed in the case of miRNA clusters 
(Altuvia, Landgraf et al. 2005). 
The quest for an alternative genetic carrier – the Nsmce2lox strain. 
The remarkable lethal interaction between Smc6S994A-neo and Mus81KO corroborated the 
hypothesis of a functional bond between the SMC5/6 complex and the metabolism of 
joint DNA molecules. The lack of homozygous animals to work experimentally, though, 
represented a major disadvantage. Therefore, in order to proceed, we crossed Mus81KO 
mice with animals carrying a conditional allele of Nsmce2 that we generated in the lab 
according to the strategy outlined in ﬁgure 39 ( Jacome et al. unpublished). 
Figure 39: Targeting strategy for the generation of the Nsmce2lox strain.  ES cells from wt animals were 
targeted with a construct bearing the ﬂoxed exon3 of Nsmce2 and a FRT-NeoR cassette for clonal selection 
purposes. Positive recombinants were microinjected in fertilized oocytes to generate the mouse strain 
employed. 
"74
Results - part I
Nsmce2Δ/Δ animals show an extended array of genomic instability features at the cellular 
level. Notably, cells depleted for NSMCE2 present a significant increase in SCE levels, 
(again, similarly to BLM-deficient cells), as well as a marked tendency to micro-
nucleation. Additionally, Nsmce2Δ/Δ cells exposed to cross linking agents (such as MMS) 
leads to gross chromosomal aberrancies like the accumulation of radial chromosomes, 
recapitulating once more a molecular feature of Blm cells. 
In vivo, the loss of NSMCE2 leads to a progressive and generalized progeroid syndrome, 
to which animals succumb within less than a year. Nsmce2Δ/Δ animals exhibit a number of 
pathologies which are also found in Bloom’s patients, among which altered pigmentation, 
a reduced percentage of body fat, progressive anemia and a marked accumulation of 
micronuclei in cells with high proliferative turnovers such as the epithelium of the 
intestinal crypts (Lönn and Lönn 1990). 
Considering our previous thwarted eﬀorts when using ﬁbroblasts, we decided to 
highlight any functional implications of the Nsmce2Δ/Δ-Mus81KO genetic combination in B-
lymphocytes, a paradigmatic cellular model where to study genomic instability for their 
tolerance to replication stress. In order to obtain experimental B cells, we intercrossed 
the newly generated strain with a Tg.CD19Cre line (Rickert, Roes et al. 1997), allowing for 
B-lineage restricted deletion of Nsmce2. Additionally, we devised to extend our analysis 
to embrace the different nucleases implicated in resolution and planned to ablate the 
whole set genetically. The absence of striking phenotypes observed in vivo upon the 
depletion of MUS81, as well as our results in vitro after the partial shRNA mediated 
silencing of Gen1 and Slx4, were indeed supporting the possibility of a "functional 
takeover" by the different redundant nucleases implicated in resolution and were 
suggesting, at the same time, the need for a genetic approach, rather than a simple 
downregulation of the proteins. 
We thus planned for crossing Gen1KO animals with conditional Slx4lox animals and 
Nsmce2lox conditionals, to ﬁnally generate a mixed Slx4lox -Nsmce2lox - GenKO strain. This last 
model represents the most comprehensive genetic tool where to observe functional 
interactions between the SMC5/6 complex and the resolution machinery. SLX4, as 
previously mentioned, act as a docking platform regulating the activity of both MUS81 
and SLX1, and its deletion hinders the activity of both partners. The conditional deletion 
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of SLX4 in our Slx4lox -Nsmce2lox - GenKO strain would hence allow for a complete abrogation 
of the nucleases described to play a role in resolution. While the mice were being 
generated, we performed a ﬁrst series of exploratory experiments on the Nsmce2lox-
Mus81KO line, still devoid of lineage-speciﬁc Cre. MEFs from Nsmce2lox/lox–Mus81KO/KO 
animals, as well as single mutant and wt controls were used for these trials.  
We ablated the ﬂoxed allele by transducing cells with a Cre-encoding adenovirus and 
after verifying the actual depletion of NSMCE2 (ﬁgure 40), cells were analyzed for 
highlights of genomic instability.  
Figure 40: The transient expression of Cre eﬀectively ablates Nsmce2 in MEFs. Fibroblasts from E13.5 
embryos were transduced with AdenoCre and the actual depletion of NSMCE2 was monitored 72hrs post 
infection (resulting in a virtually complete silencing). 
As in our previous attempts, we employed these MEFs to verify their spontaneous 
tendency to genomic instability. Hence, we quantiﬁed their tendency to micronucleation 
and polynucleation, as in ﬁgure 41. 
Figure 41: Lack of a phenotypical synergy between Nsmce2 and Mus81 in MEFs from Nsmce2lox-Mus81KO 
animals. CRE-treated cells from the double homozygous animals are mildly prone to instability, but they 
seem to show no synergy between the detrimental eﬀect of NSMCE2 ablation and MUS81 depletion. 
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Deletion of Mus81 in a Nsmce2Δ/Δ background rescues increased recombination 
rates but doesn’t grossly affect cell viability 
A peculiar feature of Blm mutant cells, as previously mentioned, is the pronounced 
tendency to sister chromatid exchanges. 
As outlined, the Nsmce2lox mouse model recapitulates many of the features of Blm cells, 
in support of our original hypothesis of a genetic and functional equivalence Blm ≡ 
Nsmce2. Among them, comparable rates of spontaneous sister chromatid exchanges. As 
recently reported in human cells (Wechsler, Newman et al. 2011) such phenotype can be 
reverted, in Blm cells, by the concomitant depletion of MUS81. According to our model, 
the depletion of MUS81 in Nsmce2Δ/Δ cells should result in the same reversal. We hence 
decided to verify the behaviour of Nsmce2Δ/Δ - Mus81KO cells, performing SCE assays at 
mitosis with AdCre treated Nsmce2lox - Mus81KO 
Interestingly, we could indeed conﬁrm what expected, as in ﬁgure 42. 
Figure 42: The deletion of Mus81 reverts the sister chromatid exchange phenotype observed in 
Nsmce2lox cells. Depleting NSMCE2 in replicating cells results in an increased rate of SCEs, as in the case of 
Blm (left panel). Similarly to what observed in Blm cells, MUS81 depletion in a Nsmce2Δ/Δ background 
produces a reduction of sister chromatid exchange events (as quantified in the dot plots – right panel). 
As in the previous cases, MEFs showed the a-speciﬁc eﬀects of the experimental 
manipulation necessary to ablate Nsmce2. Though AdCre-treated Nsmce2lox MEFs showed 
a mild tendency to accumulate micronuclei and to undergo polynucleation, we failed to 
highlight a synergy between then concomitant depletion of NSMCE2 and MUS81, 
presumably due to the aspeciﬁc proliferative arrest induce on ﬁbroblasts by the AdCre 
transduction. 
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The detrimental eﬀect of AdCre on cell proliferation was conﬁrmed in the colony forming 
assays (CFAs) performed on Nsmce2lox/lox – Mus81KO/KO cells and relevant controls (ﬁgure 
43). 
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Figure 43: Nsmce2Δ/Δ: Mus81KO MEFs show similar growth disadvantages to Nsmce2Δ/Δ and Mus81KO 
cells. Primary MEFs were extracted at E13.5, immortalized by SV40T121 and transduced with AdCre and 
plated to test survival and colony formation Surviving colonies were scored after 15 days. In addition to a 
non-specific toxic effect of the immortalization procedure and the detrimental effect of Cre transduction, 
which are evident in all but wt cells, double homozygous cells didn’t show a stronger growth disadvantage 
than control counterparts upon NSMCE2 depletion. 
As evident from the results of the CFAs, genetically modiﬁed cells transduced with the 
AdenoCre virus underwent proliferation arrest, and such tendency was particularly 
evident in the case of Mus81KO cells. This response was once more jeopardizing the 
possibility to quantify the eﬀects of our genetic background on cell survival in MEFs, and 
was suggesting to focus on an alternative cellular model. 
We thus analyzed B-lymphocytes obtained from our Nsmce2lox-Mus81KO-CD19Cre model, 
searching for instability phenotypes that could corroborate the function interplay Mus81-
Nsmce2. 
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For that purpose, we extracted cells from the spleen of experimental animals and 
checked for the eﬀective cleavage on Nsmce2 operated by the endogenous Cre, verifying 
its eﬃcacy (ﬁgure 44).  
Figure 44: Eﬀective depletion of NSMCE2 in Nsmce2lox-Mus81KO-CD19Cre animals. The CD19Cre used in 
our strain eﬀectively process Nsmce2 in B-cells, as highlighted by Western blot. As in the right panel, organs 
obtained from double homozygous animals didn’t show dysplasia nor diﬀer macroscopically from the ones 
of control animals. 
According to our preliminary hypothesis, a mutant for Nsmce2 and Mus81 should show 
the negative eﬀects of the excessive accumulation of joint DNA replication 
intermediates.  
We were reasoning, as previously underlined, that the concomitant impairment 
resolution (resulting from the deletion of Mus81) and dissolution (originating from the 
ablation of Nsmce2) would result in synthetic sickness, producing an array of detrimental 
consequences in actively replicating cells. We thus ﬁrst analyzed B-lymphocytes from our 
animals macroscopically, and focused on parameters such as cellular morphology and 
size. Genomic aberrations like aneuploidy and gross chromosomal rearrangements 
commonly reﬂect in alteration of nuclear morphology (Gisselsson, Björk et al. 2001). In 
the case of B-cells, nuclear abnormalities would obviously result in cellular 
dysmorphism, due to the prominent size of their nucleus. Interestingly, in agreement 
with this, the concomitant deletion of Nsmce2 and Blm in B-cells leads to the formation of 
multilobulated nuclei ( Jacome et al. unpublished)  
We monitored the proliferation rates of Nsmce2lox-Mus81KO-CD19Cre cells, taking into 
account that deregulated proliferation is one of the most clinically relevant readouts of 
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genomic instability. Once again, despite our expectations, no clear diﬀerence was 
noticeable among diﬀerent samples.  
As in ﬁgure 45-A, no macroscopic diﬀerence was evident between cells derived from 
experimental animals and controls. The gross morphology of Nsmce2lox-Mus81KO-CD19Cre 
and relevant controls wasn’t diﬀering, as suggested from the SSC and FSC of cells 
samples analyzed by FACS (ﬁgure 45-B). At the molecular level, we could not highlight 
major chromosomal aberrancies, either (ﬁgure 45 panel B - right). 
Intriguingly, we could once again verify, in this alternative cell type, the "reversal 
phenotype" on the rate of sister chromatid exchanges that we observed in MEFs after 
the concomitant deletion of Nscme2 and Mus81 (ﬁgure 45-C). 
Figure 45: B-cells from Nsmce2Δ/Δ-Mus81KO animals don’t show relevant abnormalities.  As in panel A, 
cells from control animals and Nsmce2lox-Mus81KO – CD19Cre mice don’t show major difference in terms of 
size and morphology. In confirmation, their FSC and SSC profiles are undistinguishable (panel B). When 
checking sampled metaphases from Nsmce2Δ/Δ : Mus81KO cells, moreover, no striking features could be 
underlined. (panel B - scale bar = 10μm). Despite the lack of a clear macroscopic difference, we could notice, 
as in MEFs previously, the reversal of the SCE phenotype proper of Nsmce2Δ/Δ cells, upon the concomitant 
deletion of Mus81 (panel C).  
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This last result, conﬁrmed in two independent cell types, was suggesting the direct 
implication of MUS81 in the processing of DNA replication intermediates originating 
from the impairment of the SMC5/6 complex. While this, as previously mentioned, 
agreed with what reported for BLM deﬁcient cells (Wechsler, Newman et al. 2011), it was 
at odds with the lack of negative eﬀects on the overall health of cells. Several possible 
explanations may account for that. This could be reasonably due to cell speciﬁc eﬀects, 
primarily. The cell types we analyzed (MEFs and B-cells), which are routinely used in the 
ﬁeld for their relative tolerance to DNA damage, may represent the wrong cellular milieu 
where to study the interplay between the SMC5/6 complex and the resolution 
machinery. We can’t indeed rule out a priori the existence of uncharacterized regulatory 
mechanisms that may interfere with our analysis.  
Additionally, we can’t exclude a selective processing of diﬀerent subsets of joint DNA 
molecules. MUS81 could be speciﬁcally implicated in the recombinogenic resolution of 
joint DNA species. SLX1/4 and GEN1 would instead catalyze non recombinogenic 
resolution, preventing the accumulation of SMC5/6 related DNA intermediates (and their 
detrimental eﬀects) in the cells we analyzed.According to this hypothesis, the depletion 
of MUS81 in a SMC5/6 background would only result in the prevention of sister 
chromatid exchanges, without major consequences in terms of cellular health, as we 
eﬀectively observed. 
In conclusion, we esteem that further experiments on the Slx4lox -Nsmce2lox - GenKO strain 
being currently generated in the lab may help shed a light on the actual role of the 
SMC5/6 in the metabolism of joint DNA molecules. 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Results - part II 
Molecular characterization of the resolution nucleases 
While we concentrated our eﬀorts on working genetically to deﬁne the interplay 
between the SMC5-6 complex with the dissolution and resolution machinery, we decided 
to explore the molecular insights of resolution, which are still vastly uncharacterized in 
higher eukaryotes.  
Our endeavours were inspired by the current regulatory model proposed for BLM/
TOPIIIα, MUS81 and GEN1 (Matos, Blanco et al. 2011). According to the latter, BLM/
TOPIIIα would operate the dissolution of DNA joint molecules all along the cell cycle, and 
exert its function, primarily, before the onset of the M-phase. After the entry in G2, 
activated Polo kinase(s) would operate a series of “licensing phosphorylations” on 
speciﬁc Ser/Thr residues of GEN1 and MUS81/EME1/Mms4, activating them and 
promoting the resolution of DNA replication intermediates that might have accumulated 
after the completion of the S-phase. (ﬁgure 46). 
Figure 46: cell cycle regulation of the activity of dissolution and resolution. According to the current 
consensus, BLM-TOPIIIα would operate a background monitoring of the accumulation of DNA replication 
intermediate all along the cell cycle. By operating phosphorylation on Ser-Thr residues of GEN1 and MUS81-
EME1, PLK1 activates the enzymes, promoting resolution post-S phase (adapted from Matos, Blanco et al. 
2011) 
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Interestingly, in agreement with the model, premature activation of Mus81 in yeast, 
achieved with phosphomimetic Mms4 variants, was shown to induce crossover-
associated chromosome translocations (Szakal and Branzei 2013). 
In summary, the dissolution machinery would operate a “background monitoring” 
preventing the accumulation of DNA joint molecules all along the cell cycle. The 
activation of endonucleases in late G2/M would represent a safeguard mechanism to 
avoid the persistency of DNA replication intermediates during mitosis. By resolving joint 
DNA molecules right before cell division, GEN1 and MUS81 would promote the correct 
segregation of chromosomes at anaphase, at the cost, though, of an increased 
probability of unbalanced sister chromatid exchanges and potential LOH.  
Taken into account such tight regulation, and the observation from yeast experiments 
mentioned above, we questioned ourselves on what could happen if nucleases were to 
be activated in the “wrong” phase of the cell cycle in higher eukaryotes.  
A plausible possibility could be that prematurely activated enzymes would operated an 
extensive processing of DNA replication intermediates accumulated during replication, 
giving rise to massive DNA damage and ﬁnally wreaking havoc on the cellular genome.  
Chromosome pulverization: a role for structure speciﬁc nucleases? 
We encountered a potential and intriguing parallelism to our question in some early 
work from the late '60, where an interesting phenomenon – chromosome pulverization – 
was reported in detail (Kato and Sandberg 1968, Matsui, Weinfeld et al. 1971). A number 
of groups almost concomitantly described the outcome of experiments where a cell in 
interphase was fused with a metaphase cell (Obe, Ludcke et al. 1975; Rao and Wilson 
1976). In such scenario, an unknown agent from the metaphase nucleus could induce 
the heterochromatization of chromosomes, either in their unreplicated or replicated form. 
Interestingly, a subset of fused cells would present the "pulverization" of the DNA 
belonging to the interphasic nucleus: minuscule chromatin fragments would accumulate 
in the heterokaryon suggesting a genomic catastrophe and the complete shattering of the 
interphase cell’s DNA (ﬁgure 47). 
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Figure 47: An unknown agent from a metaphase nucleus can induce the pulverization of an interphase 
cell’s genome.  When an heterokaryon of a metaphase and an interphase cell is formed, the chromatin of the 
interphase nucleus condensates and degenerates in a multitude of microscopic fragments, suggesting 
pulverization. 
A tempting interpretation, in agreement with the regulation model proposed for GEN1 
and MUS81, would be that the inﬂow of “licensed nucleases” (or activated cell cycle 
kinases) provided by the metaphase cell nucleoplasm (in their phosphorylated status), 
would lead to the pulverization of the DNA undergoing replication.  
We decided to test this hypothesis by performing a series of experiments on cells. 
By reviewing the literature for this purpose, in search of experimental conditions to 
replicate the chromosome shattering phenomenon, we discovered that cells treated during 
in S-phase with calyculin A (a potent Ser/Thr phosphatase inhibitor) undergo the same 
“genome pulverization” reported in cell-fusion experiments (Bezrookove, Smits et al. 
2003). This would be due to the potent inhibition operated by calyculin A on type 1 and 
type 2A protein Ser/Thr phosphatases of the PPP family, among which PP1 and PP2A, a 
negative regulator of PLK1 activity (Lu, Kovach et al. 2009). Calyculin A would thus 
increase the levels of phosphorylation of mitotic kinases in S-phase. 
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As a consequence, the persistently activated PLK1 would licence, in a disregulated 
fashion, the structure speciﬁc nucleases, inducing the shattering of replicating 
chromosomes in the wrong phase of the cell cycle. 
We hence tested for conditions that would reproduce the same results reported in the 
literature (Bezrookove, Smits et al. 2003) (ﬁgure 48). 
Figure 48: U2OS undergo chromosome condensation and S-phase pulverization upon treatment 
with calyculin A. U2OS cells treated with 80nM calyculin A for 1 hr. replicate the PCC and the S-phase 
pulverization phenotypes reported (Bezrookove, Smits et al. 2003). 
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Therefore, we treated with calyculin A U2OS cells or NIH3T3 ﬁbroblasts according to the 
established conditions. 
We thus monitored the accumulation of 53BP1 foci in cells exposed to calyculin to 
determine whether the conditions generating chromosome pulverization generate 
actual DNA breaks. (ﬁgure 49). 
 
Figure 49: Treatment of cells with calyculin A doesn’t promote the accumulation of 53BP1 foci in cells. 
U2OS or NIH3T3 cells treated with a short pulse of 80 nM calyculin don’t show accumulation of DNA double 
strand breaks (indirectly monitored by immunoﬂuorescence against 53BP1). 
Since we failed to notice such response, we inferred that the short-term inhibition of 
PP2A and PP1 wouldn’t result in the misregulated activation of structure speciﬁc 
nucleases, at least inside the time interval we chose for the experiment.  
The toxicity of calyculin could be accounted for the lack of DSB in treated cells, since we 
couldn’t indeed rule out a negative eﬀect of proliferation of our treatment.  
By preventing replication, calyculin would both counteract the generation of DNA 
replication intermediates in cells and promote, contemporarily, the disregulated 
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activation of GEN1 and MUS81. As a result, the licensed nucleases would be deprived of 
their speciﬁc DNA substrates and wouldn’t hence operate. 
An alternative plausible possibility was that the pulverization phenotype we observed in 
S-phase could be due to the deregulated compaction and condensation of chromatin, 
rather than to its nucleolytic fragmentation, as historically debated (Bezrookove, Smits et 
al. 2003). With the aim of testing these speculative possibilities, we arranged for an 
alternative experimental setup. 
U2OS and NIH3T3 were grown in the presence of BrdU, a nucleotide analogue that gets 
integrated in the nascent DNA strain originating at replication. After the BrdU pulse, cells 
were treated with calyculin A as in the protocol depicted in ﬁgure 50. 
Additionally, we exposed cells to a PLK1 inhibitor that, according to our speculative 
hypothesis, would hamper the phosphorylation-mediated licensing of GEN1 and MUS81. 
After the treatments, cells were ﬁxed, stained for BrdU and DAPI, and the quantity of 
nuclei showing a pulverized phenotype was scored. 
Figure 50: The inhibition of PLK1 doesn’t aﬀect the amount of pulverized nuclei in replicating cells #1. 
The amount of cell nuclei showing a pulverized phenotype doesn’t correlate signiﬁcantly with the inhibition 
of PLK1. 
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When restricting the scoring to the BrdU+ nuclei, we observed that inhibiting PLK1 
doesn’t have an impact on the amount of pulverized nuclei appearing after calyculin 
treatment, indirectly supporting the independence of this phenomenon from the 
phosphorylation status of nucleases (ﬁgure 51). 
Figure 51: The inhibition of PLK1 doesn’t aﬀect the amount of pulverized nuclei in replicating cells #2. 
When restricting our scoring to BrdU+ nuclei, we couldn’t stress any change in the amount of nuclei 
undergoing pulverization upon PLK1 inhibition, supporting the independence of what called chromosome 
pulverization from PLK1 activation (hence, from activation of the resolution endonucleases, according to the 
current model). !
Finally, in order to directly evaluate a potential role for the resolution nucleases in 
chromosome pulverization, we pulsed U2OS cells with BrdU and then treated them with 
siRNAs against GEN1 and MUS81, verifying the eﬀective downregulation of the genes 
(ﬁgure 52-B).  
We thus exposed siRNA-treated cells to calyculin and quantiﬁed the BrdU+ metaphases 
showing a pulverized phenotype (ﬁgure 52-A) 
Figure 52: siRNA mediated down-regulation of GEN1 and MUS81 doesn’t aﬀect chromosome 
pulverization. After silentincing GEN1 and MUS81 in U2OS cells (B), we scored the number of pulverized 
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nuclei after exposing cells to a pulse of BrdU (A). Upon calyculin treatment, we couldn’t emphasize 
diﬀerences between siRNA-treated samples and control cells. 
The results shown in ﬁgure 51 and ﬁgure 52 suggest that the phenomenon of 
chromosome pulverization phenotype we observed is not mediated by the resolution 
endonucleases MUS81 or GEN1, at least in the cellular models we employed. 
Development of a platform to direct at will the activity of resolution 
nucleases 
We ﬁnally decided to explore the possibility of generating a cellular system where the 
activity of GEN1 or MUS81 could be unleashed at will. 
The rationale behind this endeavour is directly connected to our genetic exploration on 
the interplay between dissolution and resolution. Our eﬀorts were following the wealth 
of literature in yeast deﬁning the genes implicated in resolution as hubs for synthetic 
sickness interactions. Their detrimental interplay with a plethora of genes involved in the 
prevention of replication stress and genomic instability - among which members of the 
SMC5/6 complex - suggested the possibility of exploiting their lethal genetic interactions 
in mammals for clinical purposes. The pharmacological inhibition of resolution 
nucleases in genetic contexts giving rise to synthetic sickness would represent a novel 
therapeutic approach along the line with what actively pursued in the context of cancer 
biology recently (Rehman, Lord et al. 2010). 
In order to therefore test for potential inhibitors to use therapeutically, we were in need 
of appropriate screening tools to monitor and direct the action of nucleases in living 
cells. 
With this purpose in mind, we devised an artiﬁcial system aimed to control the activity of 
nucleases at will. We thus generated a chimeric version of both GEN1 and MUS81 whose 
intracellular localization could be controlled by the addition of 4-hydroxytamoxifen (4-
OHT). We assembled a retroviral system where the coding sequences of both GEN1 and 
MUS81 were fused to the tamoxifen-responsive element of the oestrogen receptor (ﬁgure 
51-A) and tested our constructs in NIH3T3 cells, verifying the expression of the chimeric 
proteins and their concentration in the nucleus upon the addition of 4-OHT (ﬁgure 53-
B). 
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Figure 53: Chimeric MUS81-ER and GEN1-ER are expressed in cells and  translocate to the 
nucleus upon administration of 4OHT. NIH3T3 cells were transduced with either MUS81-ER or 
GEN1-ER (panel A), sorted for top GFP expression and treated with 4-OHT. Upon tamoxifen 
treatment, both proteins eﬀectively translocate to the nucleus (panel B) 
After these initial veriﬁcations, we checked whether the re-localization to the nucleus 
would produce DSBs on the cells' DNA. Therefore, we employed NIH3T3 cells transduced 
with MUS81-ER, which were sorted for high GFP expression and examined, by high-
throughput microscopy, the accumulation of nuclear 53BP1 foci (i.e. the generation of 
DSBs on chromatin) upon the administration of 4-OHT. We concomitantly treated cells 
with 2mM hydroxyurea, which we reasoned could increase the amount of nucleases 
substrates by promoting the generation of DNA joint molecules (ﬁgure 54).  
We indeed hypothesized that by increasing the concentration of DNA replication 
intermediates, hence favouring the activity of structure speciﬁc endonucleases, we 
should obtain a clearer response from our experimental system. 
!
!
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Figure 54: U2OSMUS81ER cells respond to HU, accumulating 53BP1 independently of MUS81-ER 
overexpression and localization. U2OS transduced with MUS81-ER, sorted for GFP expression and 
treated incrementally with HU show a mild proportional accumulation of 53BP1 foci. Such 
accumulation though, does not correlate with the nuclear concentration of MUS81. 
While a positive trend in the accumulation of nuclear 53BP1 after HU treatment was 
noticeable, we couldn’t see any increase of 53BP1 foci after the administration of 4-OHT 
to cells.  
The same result was conﬁrmed when we repeated this experimental strategy with 
murine NIH3T3 cells (ﬁgure 55). As highlighted by the immunoﬂuorescence against 
53BP1, no major increase in the quantity of DSBs foci could be noticed after the 
administration of 4-OHT to cells. 
"92
Results - part II
 
Figure 55: Nuclear overexpression of GEN1 and MUS81 doesn’t boost the processing of replication 
intermediates in NIH3T3 ﬁbroblasts. We directly visualized the accumulation of nuclear 53BP1 foci in 
NIH3T3 cells upon the induction of replication stress through the administration of hydroxyurea. No clear 
correlation between OHT treatment (i.e. relocalization of endonucleases to the nucleus) and 53BP1 foci 
could be emphasized. Scale bar: 50μM 
In summary, these experiments suggested that the overexpression and relocalization of 
structure speciﬁc nucleases to their site of action is not suﬃcient for triggering their 
activity in interphase cells. The lack of a coordination with the endogenous regulation of 
these enzymes might account for such lack of feedback. Additionally, the nuclear 
saturation resulting from the ER-driven localization might interfere with the correct 
processing of DNA replication intermediates, hampering the any functional response. 
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Furthermore, the steric hindrance of the ER moiety we fused to the sequence of MUS81 
and GEN1 could represent an additional technical drawback. The presence of an 
exogenous protein sequence attached to the protein backbone may result in the 
alteration of the enzymatic activity of the "chimeric" nucleases, hence frustrating the 
possibility of employing them to process DNA replication intermediates at will.  
In summary, several optimizations could be applied in order to improve the synthetic 
platform we envisioned and tentatively tested.  
We are indeed convinced of the validity of our approach, and we’re conﬁdent that 
further developments may lead to an optimized platform to harness, on the long term, 
the therapeutic potential embraced by the metabolism of joint DNA molecules  
"94
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
Discussion 
A B
Discussion - Part I
Discussion 
Part I: Framing the role of SMC5/6 in metazoans: the need for experimental 
tools. 
Our study represents a tentative approach towards a comprehensive characterization of 
the SMC5/6 complex in metazoans. The very lack of a common name recalling its 
function is, by itself, quite a telling feature, diﬀerentiating the complex from its closest 
partners, cohesin and condensin. As previously mentioned, the SMC5/6 dimer is 
essential both in lower and higher eukaryotes (Ju, Wing et al. 2013; Lehmann, Walicka et 
al. 1995), and this has historically represented a major drawback, discouraging any 
genetic endeavours aimed at deﬁning its function in metazoans. 
As a demonstration of our knowledge gap, at today’s date, most literature on the 
function of the human SMC5/6 dimer derives from studies based on the siRNA depletion 
of its individual components (Potts and Yu 2005; Potts, Porteus et al. 2006, Potts and Yu 
2007; Behlke-Steinert, Touat-Todeschini et al. 2009). Only recently a ﬁrst tentative 
approach of gene targeting , performed in chicken DT40 cells (Stephan, Kliszczak et al. 
2011), has provided some surprising data on the essentiality of the complex in 
metazoans. 
We explored this scenario along the line traced by yeast literature and develop mouse 
models recapitulating the SMC5/6 phenotypes described in lower eukaryotes.   
Nsmce2 is an essential gene in higher eukaryotes, while its SUMO ligase activity is 
dispensable. 
The ﬁrst endeavour of the lab - a KO mouse for Nsmce2 - yielded a perfect correlation 
with the yeast data. As observed in both S. cerevisiae and S. pombe (Giaever, Chu et al. 
2002; Kim, Hayles et al. 2010), Nsmce2KO mice are unviable, aborting development at the 
blastocyst stage (Jacome et al. unpublished). 
The next approach undertaken - a functional impairment of NSMCE2, rather than its 
systemic deletion - represented a successful compromise to overcome the lethality 
observed in the Nsmce2KO mice.  
The strategy to abrogate the SUMO ligase activity of NSMCE2 was corroborated 
experimentally, since we could verify that the SP-RING mis-sense C185S;H187A 
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mutations, originally described and featured in S. pombe (Andrews, Palecek et al. 2005), 
equally aﬀected the murine protein and severely impaired its activity towards SUMOs.  
Despite a mild instability phenotype highlighted in cells, mice bearing the mutation 
didn’t show altered ﬁtness, and their overall health and survival was unaﬀected. These 
data well agree with many reports on SUMO biology in Vertebrates. Whilst SUMOylation 
is essential for viability in S. cerevisiae (Giaever, Chu et al. 2002) , in metazoans its function 
is at least partially dispensable (Zhang, Mikkonen et al. 2008) 
NSMCE2: a bona ﬁde SUMO2 ligase in higher eukaryotes. 
When characterizing biochemically NSMCE2SD, we could highlight its SUMO2-ligase loss of 
function, with only a partial eﬀect on SUMO1 conjugation, suggesting that NSMCE2 is a 
bona ﬁde "SUMO2-preferring" ligase in higher eukaryotes. Even though we could 
pinpoint a functional bias towards SUMO2, we cannot rule out the possibility of a 
SUMO1 conjugating activity of the protein in vivo, considering that NSMCE2 has been 
described as a SUMO1 ligase in alternative biological systems (Potts and Yu 2005).  
It is important to remark how the speciﬁcity towards SUMO paralogues exerted by the 
handful E3 ligases encoded in metazoans is still rather uncharacterized. A certain 
“isoform versatility” is often observed when performing SUMOylation experiments in 
vitro, as in the case of enzymes with a deﬁned isoform preference in vivo (Vertegaal, 
Andersen et al. 2006). 
NSMCE2SD cells as a platform to deﬁne the NSMCE2 SUMOylome 
The Nsmce2SD model we developed represented a tentative instrument to characterize of 
the NSMCE2 SUMOylome in vivo. 
As previously mentioned, only few NSMCE2 targets have been described in higher 
eukaryotes - among them SMC6, SMC5, NSMCE2 itself and some members of the 
shelterin complex at telomeres (Potts and Yu 2007). Most data in this context originates 
from in vitro conjugation experiments, an approach bearing intrinsic ﬂaws that we 
wanted to overcome.  
We designed for the purpose diﬀerent tagged versions of SUMOs to speciﬁcally identify 
the NSMCE2-modiﬁed fraction of the proteome in vivo, and took advantage of SUMO-dead 
immortalized ﬁbroblasts as a semi-endogenous expression platform. We reasoned that, by 
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comparing puriﬁed lysates from wild-type cells and SUMO-dead counterparts by mass 
spectrometry, we should come across a pattern of SUMOylated proteins that would not 
be represented in the NSMCE2SD puriﬁed sample. Their exclusive presence in the wild-
type pool would hence signify that NSMCE2 is implicated in their SUMOylation. 
After embarking in such endeavour, we soon encountered a variety of major downsides. 
As previously mentioned, murine ﬁbroblasts are often refractory to exogenous protein 
expression, and despite the possibility of enriching for the top expressing cell 
populations, we constantly obtained very low yield of SUMO-overexpression in our 
samples.  
Additionally, top expressors commonly responded to the high load of SUMOs either 
arresting proliferation or quenching the expression of the construct transduced 
(probably by epigenetic silencing). Whenever suﬃcient amounts of overexpression could 
be obtained (allowing for the detection of free SUMO in cells by Western blot), we 
routinely tested for the presence of SUMO-modiﬁed SMC5-SMC6 or NSMCE2 as 
experimental validation, failing to detect any of these described targets. 
A possible explanation may be linked to the intrinsic lability of SUMOylation as a post-
translational modiﬁcation. Additionally to its transitory nature (Geiss-Friedlander and 
Melchior 2007), the puriﬁcation and subsequent detection of SUMO-modiﬁed proteins 
can be hampered by their paucity in pooled samples.  
In summary, we esteem that a variety of synergistic factors frustrated our quest for the 
endogenous targets of NSMCE2: a poor overexpression platform, the relative scarcity of 
NSMCE2 targets in the proteome, and the poor sensitivity of our validation system.  
As outlined previously, there would be several ways to boost our approach. As an 
example, we could take advantage of recent optimized pipelines for the puriﬁcation of 
endogenously SUMOylated targets (Becker, Barysch et al. 2013). Alternatively, we could 
focus on endogenous SUMOylation by speciﬁcally labelling SUMO genes through 
genome editing, avoiding thus the issues provoked by overexpression of exogenous 
SUMO in cells. 
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Nsmce2SD cells show an instability signature with no major consequences at the 
organism level 
An interesting feature of our Nsmce2SD model is the recapitulation, at least at the cellular 
level, of the instability phenotype observed in yeast mms21 and sgs1/Blm mutants. 
Similarly to the yeast case, we could verify that the impairment of the SUMO ligase 
activity of NSMCE2 brings about an increased sensitivity towards replication stress and 
the associated DNA damage in vitro (Andrews, Palecek et al. 2005). We reckoned such 
similarity by quantifying the nuclear by-products of aberrant DNA segregation in 
replicating cells - micronucleation and polynucleation - which are routinely employed as 
readout of genomic instability in cells (Fenech, Kirsch-Volders et al. 2011). While Nsmce2SD 
cells behaved according to our expectations, based on the accumulated evidence in 
lower eukaryotes, we were surprised by the lack of a reﬂected phenotype in vivo. 
Even though no changes in the survival rates of SUMO-dead mice could be highlighted, 
yet the animals showed a tendency to spontaneous colon tumour formation, as 
underlined by their worse response to induced tumorigenesis, again recapitulating an 
hallmark of the Bloom syndrome. 
Combining Nsmce2SD with Mus81KO doesn’t aﬀect ﬁtness. 
These observations, together with the mild instability signature observed at the tissue 
level, led us to employ the SUMO-dead strain as a ﬁrst chassis for genetic permutations 
with the resolution machinery. In our expectations, the negative eﬀects of the Nsmce2SD 
allele should be exacerbated by the impairment of resolution, attained by combining the 
strain with Mus81KO animals. Again unexpectedly, that didn’t prove to be the case - at 
least for the exploratory Nsmce2SD: Mus81KO cross generated. The synthetic sickness we 
hypothesized was falsiﬁed by the lack of major cellular or systemic phenotypes in double 
mutant animals. 
Resiliency and robustness characterize the processing of DNA joint molecules 
The most straightforward interpretation of our data lies in the robustness and resiliency 
of pathways such as dissolution and resolution, where several enzymes play a 
concomitant role. Though MUS81 seems to have a preeminent role in avoiding the 
accumulation of DNA joint molecules (Ying, Minocherhomji et al. 2013; Naim, Wilhelm et 
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al. 2013), the compensating eﬀects of GEN1 and SLX4-SLX1 upon its deletion can’t 
obviously be ruled out a priori.  
Our eﬀorts after the shRNA-mediated depletion of Gen1 and Slx4 in Nsmce2SD: Mus81KO 
MEFs further supported this interpretation. The experimental diﬃculties we 
encountered, together with the lack of speciﬁc eﬀects, was suggesting the need for a 
genetic deletion, rather than a simple depletion, of these fundamental inter-players.  
Smc6S994A-neo as an alternative genetic chassis to deﬁne the SMC5/6 – resolution 
interplay 
In order to gain further insights and to overcome the lack of a well-deﬁned phenotype 
encountered with the Nsmce2SD mice, we opted for an alternative genetic carrier. The 
recently published hypomorphic Smc6S994A-neo model ( Ju, Wing et al. 2013) responded to 
our need for a functional mutation of SMC5/6 that would bear a marked and 
quantiﬁable phenotype. Intriguingly, the Smc6S994A-neo - Mus81KO strain showed rather 
dramatic synthetic lethality, which frustrated our ability to obtain both experimental 
animals and cells.  
While on one side this strongly supported our starting hypothesis of a functional 
interplay SMC5/6 - resolution, it also suggested that, intriguingly, NSMCE2 and SMC6 
could possibly possess a similar contextual role (the prevention of DNA replication 
intermediates) exerted through diﬀerent molecular pathways, opening the possibility of 
further genetic dissection. 
The additional ﬁnding of the genetic linkage between Gen1 and Smc6 called our 
attention. As mentioned, it might represent the result of a tight interdependence of the 
two genes, which would undergo selective pressure to transmit across generations as a 
single functional unit, as in the case of many non coding DNA elements (such as miRNAs) 
(Altuvia, Landgraf et al. 2005). 
Smc6S994A-neo is synthetic lethal with Mus81KO - the need for an alternative platform  
The scenario illustrated by the Smc6S994A-neoMus81KO intercross, which somehow 
complemented the lack of phenotypes of Nsmce2SD-Mus81KO  animals, was the reason to 
translate our genetics towards a novel carrier - a conditional strain for Nsmce2 that 
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recapitulated extensively Blm/Sgs1 phenotypes, recently developed in the lab (Jacome et 
al. unpublished). 
In order to reduce the experimental noise represented by the action of GEN1 and SLX1 
in the absence of MUS81, and to highlight potential phenotypes that may be hidden by 
this redundancy, we proceeded to generate concomitantly a conditional Nsmce2lox - 
Mus81KO and a Nsmce2lox-Gen1KO-Slx4lox strain.  
The latter represented the optimal experimental tool for our studies since it allowed to 
overcome genetically the issues encountered employing shRNA procedures to depleting 
structure speciﬁc nucleases. As previously mentioned, moreover, targeting Slx4 would 
contemporarily impair the function of MUS81 and SLX1, taking into account that SLX4 
has been described as a coordinating platform for the activity of these two enzymes 
(Fekairi, Scaglione et al. 2009).  
In addition to its bifaceted eﬀect, the rationale for deleting Slx4 instead of directly involving 
MUS81 was due to the synthetic lethality reported for Gen1KO: Mus81KO mice (Matthews 
et al. unpublished data). 
The choice of a conditional allele for Slx4 and Nsmce2 was due to the lethality observed 
both in our Nsmce2KO mouse model and in the Slx4KO strain (Castor, Nair et al. 2013). It 
allowed us, moreover, to specify the working cell model, overcoming the experimental 
ﬂaws of ﬁbroblast, a cell type which often arrested replication after experimental 
manipulation, hampering the possibility of stressing any replication-related phenotype 
related to the underlying genetics. 
We hence generated both a by Nsmce2lox - Mus81KO CD19Cre and a Nsmce2lox-Gen1KO-Slx4lox 
CD19Cre to narrow our analysis on B-lymphocytes, a versatile system where we could 
take advantage of a genetically-encoded Cre. 
MUS81 processes the recombination intermediates leading to SCEs in Nsmce2Δ/Δ 
cells. 
Interestingly, we could and conﬁrm a reported phenotype associated with the 
concomitant ablation of Blm and the silencing of MUS81 in human cells (Wechsler, 
Newman et al. 2011). While Nsmce2Δ/Δ primary fibroblasts undergo SCEs with a frequency 
comparable to that of Blm cells, the absence of MUS81 reverts the phenotype to control 
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levels, suggesting the specific implication of MUS81 in the processing of recombination 
intermediates arising from the impairment of SMC5/6 Our additional  observations in 
Nsmce2lox - Mus81KO CD19Cre reinvigorated the similar observations preliminarily obtained 
in MEFs.  
Though we could indeed reconﬁrm the SCE reversion phenotype previously outlined, 
surprisingly, no additional cellular parameters resulted being aﬀected. 
While this unexpected result may be related to the cell speciﬁc eﬀects, it also 
corroborated the intriguing possibility of a separation of function between Nsmce2 and 
the core SMC5/6 complex in their interplay with Mus81. The dramatic lethality of the 
Smc6/Mus81 genetic combination we analyzed could in fact result from the impairment 
of a yet-to-deﬁne regulatory mechanism operated by the SMC5 core complex 
independently from the function of Nsmce2. 
Nsmce2Δ/Δ: Mus81KO MEFs don’t show signs of synthetic sickness. 
Apart from the interesting observation on the SCE rates, the preliminary analysis we 
performed on Nsmce2Δ/Δ-Mus81KO MEFs failed to stress any signature of synthetic 
sickness. 
Again, due to a probable redundancy of function between MUS81 and the alternative 
resolution nucleases, the overall “well-being” of cells didn’t result aﬀected negatively by 
the underlying genetics. We did notice once more, instead, the detrimental eﬀects of the 
experimental manipulation mentioned above. The adenoviral transduction of Cre, as 
well as the retrovirus-mediated transduction of SV40T121 profoundly aﬀected several of 
the parameters we assayed - notably, cell proliferation and the rates of micronucleation 
and polynucleation.  
The SMC5/6 complex: coordinating dissolution? 
In conclusion, our genetic ﬁndings generally supported the hypothesis of a functional 
relationship between the SMC5/6 complex and resolution in metazoans, framing its role 
in the context of dissolution, similarly to the case of S. cerevisiae and pombe (Bermudez-
Lopez, Ceschia et al. 2010, Branzei, Sollier et al. 2006).  
The phenotypes of the Nsmce2 mutants we involved in our study recapitulated what 
observed in yeast (at least at the cellular level, in the case of the Nsmce2SD allele). Whilst 
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we failed to highlight a strong in vivo phenotype when combining Nsmce2 mutations with 
Mus81 deletion, we could verify that aﬀecting directly the core of the SMC5/6 complex 
(the Smc6S994A-neo allele) on a Mus81-null background results in synthetic lethality (ﬁgure 
56-A). 
Such a drastic phenotype, standing somehow at opposite extreme of what observed 
when distressing the function of NSMCE2, strongly suggested that the SMC5/6 shouldn’t 
be considered as a single functional unit, but rather that it could operate as a regulatory 
platform coordinating diﬀerent pathways implicated in the processing of joint DNA 
molecules, as depicted in ﬁgure 56-B. 
Figure 56: Genetic permutation between the SMC5/6 complex and the resolution machinery. Our 
study suggest the implication of the SMC5/6 complex in the processing of joint DNA molecules in higher 
eukaryotes. While the concomitant impairment of Nsmce2 and Mus81 produces minor detrimental 
consequences, perturbing the core complex in a Mus81KO background results in synthetic lethality (panel A). 
These contrasting outcomes support the idea of the SMC5/6 as a coordinating interface for diﬀerent 
molecular pathways (panel B) 
Further genetic dissection of the speciﬁc function of diﬀerent members of the SMC 
complex could probably shed a light on the reason for the synthetic lethality we 
observed, as well as for the mild phenotype generated by altering the function of 
NSMCE2 alone.  
The transition from replication to cytokinesis and the traﬃcking of DNA joint 
molecules through dissolution and resolution 
In our speculative view, the combined impairment of dissolution and resolution would 
result in an anomalous accumulation of DNA joint molecules after replication. The 
"traﬃc jam" resulting would promote the formation of anaphase bridges at cytokinesis, 
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resulting ﬁnally in unbalanced chromosome segregation and additional genomic injuries 
that could further degenerate into LOH and, potentially, cancer.  
Our ﬁndings supported a scenario like the one depicted in ﬁgure 57.  
By concomitantly mutating NSMCE2 and impairing of the resolution machinery (knocking-
out MUS81), we compromised the processing of joint DNA molecules and veriﬁed, at 
least at the cellular level, the instability features associated.  
Figure 57: hampering dissolution and resolution through mutations aﬀecting NSMCE2 and MUS81 
resulted in mild instability in vivo. The lack of a strong phenotype after the impairment of the processing 
of replication intermediates probably result from the intrinsic resiliency of redundant systems to 
perturbation.  
SMC5/6 mutants phenocopy Blm mutations in higher eukaryotes, but the complex 
may operate on diﬀerent pathways. 
It's important to stress again how our strategy to impair dissolution relied on mutating 
functionally some of the proteins of the SMC5/6 complex – namely, Nsmce2 and Smc6 – 
taking into account the justiﬁed assumption of a genetic synonymy between Smc5/6 and 
Blm. One possibility to explain the lack of major consequences in the case of the Nsmce2/
Mus81 genetic combination might imply the functional up-regulation of dissolution, 
through an up-regulation of Blm, as in ﬁgure 58. 
Alternatively, NSMCE2 could operate in an undeﬁned regulatory mechanism whose 
alteration might results phenotypically in dysfunctional dissolution, as outlined in ﬁgure 
59. 
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Figure 58: Blm up-regulation could compensate for the impairment of the SMC5/6 complex. A possible 
explanation to the lack of strong phenotypes observed when mutating NSMCE2 and deleting MUS81 could 
be provided by the up-regulation of Blm, the direct mediator of dissolution. 
Figure 59: the SMC5/6 complex could mediate a regulatory mechanism interplaying with resolution. 
Mutations in either the core SMC5/6 complex or in associated partners (such as NSMCE2) might result in 
"dissolution phenotypes", despite being unrelated from the actual processing of DNA joint molecules. 
In summary, rather than having a unique role in the metabolism of DNA replication 
intermediates, the SMC5/6 complex could be implicated as a regulatory hub for diﬀerent 
pathways whose alteration could have a resulting eﬀect on dissolution. As we were able 
to show, diﬀerent functional members of the complex could exert alternative roles along 
uncharacterized pathways and, as a consequence, the phenotypes associated to their 
mutation may be reﬂected to diﬀerent extents in dissolution.  
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Further genetic analysis might provide additional evidence for this possibility, as it would 
the global abrogation of resolution in a SMC5/6 mutated background. Experiments on 
the Nsmce2lox-Gen1KO-Slx4lox-CD19Cre strain we're currently generating in the lab should 
indeed help to clarify this alternative scenario. Along this line recent work in the 
literature provided the ﬁrst evidence for the consequences of abrogating nucleases in 
cells that are non proﬁcient for dissolution (Wechsler, Newman et al. 2011). The authors 
showed how the depletion of GEN1 and MUS81 in a Blm deﬁcient background results in 
a varied array of chromosomal aberrancies (ﬁgure 60-A), among which the generation 
of segmented chromosomes (ﬁgure 60-B), structures that are still poorly understood 
and so far only observed in transformed cell lines.  
We’re particularly interested in seeing whether segmented chromosomes should emerge 
from experiments in our Nsmce2lox-Gen1KO-Slx4lox model, further supporting our view of 
the SMC5/6 as a regulator of the metabolism of DNA replication intermediates. 
!
Figure 60: impairing GEN1 and MUS81 in Blm cells generates chromosomal aberrancies.  When 
structure speciﬁc nucleases are depleted in cells un-proﬁcient for dissolution, chromosomes undergo 
extensive damage (panel A) and present a segmented morphology (panel B). 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Part II - Studies on the nucleases involved in the resolution pathway 
Our eﬀorts in the context of nucleases biology were originally intended as an integrating 
and complementary side of the main genetic project.  
If on one side we planned to unravel the genomic housekeeping role of the SMC5/6 
complex through genetics, on the other we aimed at potential therapeutic strategies that 
could be supported by our genetic ﬁndings. 
Chromosome pulverization: chromatin fragmentation, deregulated condensation 
or both? 
We ﬁrst wanted to assay the potential implication of GEN1 and MUS81 in the 
phenomenon of chromosome pulverization (CP), inspired by the idea that the 
deregulated activity of endonucleases, triggered in the inappropriate part of the cell 
cycle, could wreak havoc on genomes. 
The pulverization of chromosomes has been at the centre of a long dispute. Two 
opposite interpretations have for long described it as either a general fragmentation of 
chromatin or as a partial and deregulated condensation of chromatin. Though a ﬁnal 
consensual agreement on the “condensational theory” seems to have established during 
time, the possible coexistence of both phenomena behind the same phenotypical 
outcome has yet to be falsiﬁed, experimentally (Stevens, Abdallah et al. 2010).  
With our trials, we could show that both the transient silencing of GEN1 and MUS81 in 
cells, as well as the inhibition of PLK1, the regulatory kinase proposed as a major 
regulator of resolution (Matos, Blanco et al. 2011), don't counteract the appearance of 
chromosome pulverization in replicating cells. 
These results could suggest that the levels of PLK1 inhibition and GEN1/MUS81 silencing 
attained in our experiments were insuﬃcient to inhibit CP. An alternative interpretation 
could though indicate that CP probably does not depend on the nuclease activity of 
GEN1 and MUS81, in agreement with the literature supporting the “condensational 
theory”.  
Designing a system to activate structure-speciﬁc nucleases at will 
After these descriptive experiments, we thought to operate creatively, applying in the 
context of resolution the principles of synthetic biology. We thus explored the possibility 
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of redirecting the action of nucleases at will by designing the ER-fused versions of GEN1 
and MUS81. Our goal was to establish a platform to discover nuclease inhibitors 
allowing for novel therapeutic approaches, based on the synthetic sickness interaction of 
these genes with several DNA repair mediators. 
We thus cloned an ER-endowed version of both proteins to eﬀectively control their 
cellular localization by administering 4-hydroxytamoxifen. We hypothesized that, by 
increasing the nuclear concentration of the nucleases, we should produce an increase in 
the DSBs that these enzymes operate onto joint DNA replication molecules, especially 
after challenging replication and producing and accumulation of DNA replication 
intermediates. 
Despite several eﬀorts in diﬀerent cellular models, we failed to emphasize a direct 
correlation between the double strands breaks generated on cells and the concentration 
of either GEN1 or MUS81 in the cellular nucleus.  
As previously mentioned, several phenomena may account for this lack of a real function 
of our platform in living cells. A major drawback could be the represented by the ER 
fusion strategy we employed, which involves the fusion of the protein of choice with an 
extended protein moiety from an exogenous protein. In the case of MUS81 and GEN1, 
the important "steric hindrance" of the ER fragment could be aﬀecting the processing of 
DNA structures by the nucleases, hampering the generation of a response. Additional 
work should plausibly be done on the integration of our artiﬁcial operators with the 
endogenous regulation machinery operating on dissolution. We can’t indeed rule out 
that our artiﬁcial nucleases did not work as expected for a lack of an appropriate 
phosphorylation licensing. Optimizations such as the use of phosphomimetic versions of 
the enzymes that may override the endogenous regulation could potentially result in a 
functional system  
We are strongly convinced that this approach should be of great help in developing 
therapeutic strategies targeting the accumulation of joint DNA molecules in the future.  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Part I 
• The Nsmce2SD mutant allele developed in our laboratory severely compromises 
NSMCE2-dependent SUMOylation activity. 
• In agreement with yeast data, Nsmce2SD animals showed features in vitro which have 
been linked to problems on the “dissolution” of joint DNA molecules, including 
micronuclei or increased levels of recombination. 
• In contrast, Nsmce2SD animals are born at Mendelian ratios, are fertile and show a 
normal lifespan that demonstrates how NSMCE2-dependent SUMOylation is largely 
dispensable for ﬁtness. 
• An SMC6 mutant allele is synthetic lethal with MUS81 deﬁciency in mice, illustrating 
that mutations compromising dissolution and resolution activities lead to severe 
consequences. 
• In contrast, no eﬀect of MUS81 deﬁciency is detectable on Nsmce2SD mice, reinforcing 
the lack of a strong phenotype on these animals. 
• Deletion of MUS81 reverts the increased recombination rates observed on NSMCE2 
deﬁcient cells, suggesting that MUS81-mediated resolution takes care of the joint 
molecules that cannot be dealt by the SMC5/6 complex. 
• Surprisingly, no obvious defect on the overall ﬁtness is observed on NSMCE2 deﬁcient 
B cells or MEF upon deletion of MUS81. Given the eﬀects observed with the SMC6 
mutant allele, it remains possible that more pronounced eﬀects could be observed in 
other cell types, particularly during embryonic development. 
Part II 
• The phenomenon of chromosome pulverization does not depend on the activity of 
PLK1 kinase or MUS81 and GEN1 nucleases- 
• Translocating MUS81 or GEN1 nucleases into the nucleus of S phase cells is not 
suﬃcient to trigger their activity, suggesting that additional layers of regulation might 
restrict their activity to mitotic cells.  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